<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">29736</article-id><article-id pub-id-type="doi">10.7554/eLife.29736</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Computational and Systems Biology</subject></subj-group></article-categories><title-group><article-title>CDK9-dependent RNA polymerase II pausing controls transcription initiation</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes" id="author-93018"><name><surname>Gressel</surname><given-names>Saskia</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-0261-675X</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" equal-contrib="yes" id="author-93019"><name><surname>Schwalb</surname><given-names>Björn</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-2987-2622</contrib-id><email>bjoern.schwalb@mpibpc.mpg.de</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-93020"><name><surname>Decker</surname><given-names>Tim Michael</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-93021"><name><surname>Qin</surname><given-names>Weihua</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-86373"><name><surname>Leonhardt</surname><given-names>Heinrich</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-10005"><name><surname>Eick</surname><given-names>Dirk</given-names></name><email>eick@helmholtz-muenchen.de</email><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-1378"><name><surname>Cramer</surname><given-names>Patrick</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-5454-7755</contrib-id><email>patrick.cramer@mpibpc.mpg.de</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution content-type="dept">Department of Molecular Biology</institution><institution>Max-Planck-Institute for Biophysical Chemistry</institution><addr-line><named-content content-type="city">Göttingen</named-content></addr-line><country>Germany</country></aff><aff id="aff2"><label>2</label><institution content-type="dept">Department of Molecular Epigenetics</institution><institution>Helmholtz Center Munich, Center of Integrated Protein Science</institution><addr-line><named-content content-type="city">Munich</named-content></addr-line><country>Germany</country></aff><aff id="aff3"><label>3</label><institution content-type="dept">Department of Biology II</institution><institution>Ludwig-Maximilians-Universität München, Center of Integrated Protein Science</institution><addr-line><named-content content-type="city">Martinsried</named-content></addr-line><country>Germany</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1425"><name><surname>Jones</surname><given-names>Katherine A</given-names></name><role>Reviewing Editor</role><aff><institution>Salk Institute for Biological Studies</institution><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date date-type="publication" publication-format="electronic"><day>10</day><month>10</month><year>2017</year></pub-date><pub-date pub-type="collection"><year>2017</year></pub-date><volume>6</volume><elocation-id>e29736</elocation-id><history><date date-type="received" iso-8601-date="2017-06-19"><day>19</day><month>06</month><year>2017</year></date><date date-type="accepted" iso-8601-date="2017-10-06"><day>06</day><month>10</month><year>2017</year></date></history><permissions><copyright-statement>© 2017, Gressel et al</copyright-statement><copyright-year>2017</copyright-year><copyright-holder>Gressel et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-29736-v2.pdf"/><abstract><object-id pub-id-type="doi">10.7554/eLife.29736.001</object-id><p>Gene transcription can be activated by decreasing the duration of RNA polymerase II pausing in the promoter-proximal region, but how this is achieved remains unclear. Here we use a ‘multi-omics’ approach to demonstrate that the duration of polymerase pausing generally limits the productive frequency of transcription initiation in human cells (‘pause-initiation limit’). We further engineer a human cell line to allow for specific and rapid inhibition of the P-TEFb kinase CDK9, which is implicated in polymerase pause release. CDK9 activity decreases the pause duration but also increases the productive initiation frequency. This shows that CDK9 stimulates release of paused polymerase and activates transcription by increasing the number of transcribing polymerases and thus the amount of mRNA synthesized per time. CDK9 activity is also associated with long-range chromatin interactions, suggesting that enhancers can influence the pause-initiation limit to regulate transcription.</p></abstract><abstract abstract-type="executive-summary"><object-id pub-id-type="doi">10.7554/eLife.29736.002</object-id><title>eLife digest</title><p>Genes can contain the coded instructions to make proteins. These instructions must first be copied, or transcribed, into an intermediate molecule called a messenger RNA by an enzyme known as RNA polymerase II. Shortly after it begins, this enzyme – which is called Pol II for short – pauses, and it only starts again after it recruits other proteins, including one called CDK9.</p><p>The number of RNA copies made of a gene depends upon how many Pol II enzymes begin transcription. Pol II pausing also has an effect – if the enzymes pause for longer, less messenger RNA is transcribed. But why does this happen? One hypothesis is that paused Pol II enzymes interfere with other Pol II enzymes initiating transcription. Yet, until recently it was not possible to measure if this actually happens in living cells.</p><p>Now, Gressel, Schwalb et al. used a new biochemical method together with a compound that blocks CDK9 to measure pausing and transcription initiation for active genes in living human cells. The CDK9 inhibitor was used to make Pol II enzymes pause for longer than normal. Gressel, Schwalb et al. found that different genes responded differently to CDK9 inhibition, meaning that some remained paused for longer than others. The number of Pol II enzymes that initiated transcription was calculated by measuring how many RNA copies had been made locally at that the site of transcription. These experiments showed that blocking the release of paused Pol II strongly reduced the number of RNA copies made.</p><p>Gressel, Schwalb et al. conclude that Pol II pausing can control initiation of transcription. Cells may use Pol II pausing to adjust how many copies of an RNA are made, helping to ensure that different cell types make the appropriate number of RNA copies from a gene. Many diseases are associated with gene transcription being incorrectly regulated. This and future studies will help scientists to better understand how Pol II pausing contributes to the control of transcription in both normal and diseased cells.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>CRISPR-Cas9</kwd><kwd>TT-seq</kwd><kwd>mNET-seq</kwd><kwd>CDK9</kwd><kwd>RNA polymerase II</kwd><kwd>Pausing</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000781</institution-id><institution>European Research Council</institution></institution-wrap></funding-source><award-id>TRANSREGULON</award-id><principal-award-recipient><name><surname>Cramer</surname><given-names>Patrick</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001663</institution-id><institution>Volkswagen Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Cramer</surname><given-names>Patrick</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>SFB 1064 TP A17</award-id><principal-award-recipient><name><surname>Leonhardt</surname><given-names>Heinrich</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>SFB 1064</award-id><principal-award-recipient><name><surname>Eick</surname><given-names>Dirk</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution>Max Planck Institute for Biophysical Chemistry</institution></institution-wrap></funding-source><award-id>Open-access funding</award-id><principal-award-recipient><name><surname>Cramer</surname><given-names>Patrick</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>CDK9 inhibition in human cells uncovers that Pol II pause duration regulates the frequency of productive transcription initiation.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Transcription in metazoan cells is often regulated at the level of promoter-proximal pausing (<xref ref-type="bibr" rid="bib8">Core et al., 2008</xref>; <xref ref-type="bibr" rid="bib9">Day et al., 2016</xref>; <xref ref-type="bibr" rid="bib19">Henriques et al., 2013</xref>; <xref ref-type="bibr" rid="bib37">Nechaev et al., 2010</xref>; <xref ref-type="bibr" rid="bib45">Rougvie and Lis, 1988</xref>; <xref ref-type="bibr" rid="bib53">Strobl and Eick, 1992</xref>), which can be detected by measuring the occupancy with paused Pol II by ChIP-seq (<xref ref-type="bibr" rid="bib21">Johnson et al., 2007</xref>), GRO-seq (<xref ref-type="bibr" rid="bib8">Core et al., 2008</xref>), (m)NET-seq (<xref ref-type="bibr" rid="bib34">Mayer et al., 2015</xref>; <xref ref-type="bibr" rid="bib39">Nojima et al., 2015</xref>), or PRO-seq (<xref ref-type="bibr" rid="bib25">Kwak et al., 2013</xref>). Genes with paused Pol II are conserved across mammalian cell types and states (<xref ref-type="bibr" rid="bib9">Day et al., 2016</xref>). The mechanisms underlying how Pol II pausing can regulate RNA transcript synthesis remain unclear.</p><p>Transcription of a human protein-coding gene of average length takes at least half an hour to be completed. The duration of pausing however lies in the range of minutes (<xref ref-type="bibr" rid="bib22">Jonkers et al., 2014</xref>) and does not considerably change the overall time it takes to complete a transcript. Thus, how can changes in the pause duration lead to synthesis of a different number of RNA transcripts per time? It has been suggested that a decreased pause duration goes along with a higher initiation frequency, because occupancy peaks for promoter-proximal Pol II can increase upon gene activation (<xref ref-type="bibr" rid="bib4">Boehm et al., 2003</xref>) or can remain high even when pausing is impaired (<xref ref-type="bibr" rid="bib19">Henriques et al., 2013</xref>).</p><p>The height of Pol II occupancy peaks however cannot directly inform on initiation frequency or pause duration because it depends not only on the number of polymerases that pass the pause site but also on their residence time (<xref ref-type="bibr" rid="bib13">Ehrensberger et al., 2013</xref>). A kinetic model of transcription predicted that pause duration delimits the initiation frequency and suggested that paused Pol II sterically interferes with initiation (<xref ref-type="bibr" rid="bib13">Ehrensberger et al., 2013</xref>). Indeed, modeling reveals that a paused polymerase positioned up to around 50 bp downstream of the TSS could sterically interfere with formation of the Pol II initiation complex (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). Even if a paused polymerase is located further downstream, it may still interfere with initiation if one or more additional elongating polymerases line up behind it.</p><p>The critical relationship between pausing and initiation could thus far not be tested experimentally, as no methods were available to measure initiation frequencies. A recently developed method, transient transcriptome sequencing (TT-seq) (<xref ref-type="bibr" rid="bib50">Schwalb et al., 2016</xref>), now allows to unveil the flow of polymerases as it measures local RNA synthesis rates genome-wide at nucleotide resolution.</p><p>Here we investigate whether changes in pause duration alter initiation frequency in living cells. We specifically inhibit the kinase CDK9, which facilitates Pol II pause release (<xref ref-type="bibr" rid="bib26">Laitem et al., 2015</xref>; <xref ref-type="bibr" rid="bib33">Marshall and Price, 1992</xref>; <xref ref-type="bibr" rid="bib40">Peterlin and Price, 2006</xref>), and monitor RNA synthesis and initiation frequencies by TT-seq. A combination of TT-seq data with mNET-seq data allows us to derive pause durations for active genes. We conclude that the duration of pausing can control transcription initiation at human genes, and derived determinants for CDK9-dependent pause release and initiation activation.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>CRISPR-Cas9-engineered mutation allows for specific CDK9 inhibition</title><p>To specifically inhibit CDK9, we used a chemical biology approach (<xref ref-type="bibr" rid="bib29">Lopez et al., 2014</xref>) that circumvents off-target effects of standard CDK9 inhibitors (<xref ref-type="bibr" rid="bib35">Morales and Giordano, 2016</xref>). We introduced a CDK9 analog sensitive mutation (CDK9<sup>as</sup>) into human Raji B cells by CRISPR-Cas9 (Materials and methods, <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2A–B</xref>). This allows for rapid and highly specific CDK9 inhibition with the adenine analog 1-NA-PP1 (<xref ref-type="bibr" rid="bib29">Lopez et al., 2014</xref>), which does not have any effect on wild type cells (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2C</xref>). CDK9 protein levels were unchanged in CDK9<sup>as</sup> mutant cells compared to wild type cells (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2D</xref>). After 72 hr of incubation with 1-NA-PP1, growth of CDK9<sup>as</sup> cells ceased, whereas wild type cells grew normally (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2E</xref>).</p></sec><sec id="s2-2"><title>TT-seq monitors immediate response to CDK9 inhibition</title><p>We treated CDK9<sup>as</sup> cells with 5 μM of 1-NA-PP1 for 10 min and monitored changes in RNA synthesis by TT-seq (<xref ref-type="bibr" rid="bib50">Schwalb et al., 2016</xref>), using a RNA labeling time of 5 min (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). TT-seq data were highly reproducible (Spearman correlation coefficient 1) and monitored transcription activity before and after CDK9 inhibition (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). CDK9 inhibition resulted in reduced TT-seq signals at the beginning of genes, indicating that less Pol II was released into gene bodies (<xref ref-type="fig" rid="fig1">Figure 1B</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A–B</xref>). This gave rise to a ‘response window’ revealing the distance traveled by Pol II during 10 min inhibitor treatment (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). Downstream of the response window, the TT-seq signal was largely unchanged, indicating continued RNA synthesis from Pol II elongation complexes that had been released before CDK9 inhibition.</p><fig-group><fig id="fig1" position="float"><object-id pub-id-type="doi">10.7554/eLife.29736.003</object-id><label>Figure 1.</label><caption><title>CDK9 inhibition decreases RNA synthesis in the 5’-region of genes.</title><p>(<bold>A</bold>) Experimental design. TT-seq was carried out with CDK9<sup>as</sup> cells after treatment with solvent DMSO (control) or 1-NA-PP1 (CDK9<sup>as</sup> inhibited). (<bold>B</bold>) TT-seq signal before (black) and after (red) CDK9 inhibition at the ABHD17C gene locus (75,937 [bp]) on chromosome 15. Two biological replicates were averaged. The grey box depicts the transcript body from the transcription start site (TSS, black arrow) to the polyA site (pA). (<bold>C</bold>) Schematic representation of changes in TT-seq signal showing the definition of the response window. Colors are as in (<bold>B</bold>). (<bold>D</bold>) Metagene analysis comparing the average TT-seq signal before and after CDK9 inhibition. The TT-seq coverage was averaged for 954 out of 2538 investigated TUs that exceed 50 [kbp] in length (Materials and methods). TUs were aligned with their TSS. Shaded areas around the average signal (solid lines) indicate confidential intervals (Materials and methods). (<bold>E</bold>) Violin plot showing the relative response to CDK9 inhibition for 2538 investigated TUs defined as 1 - (CDK9<sup>as</sup> inhibited/Control)<inline-formula><mml:math id="inf1"> <mml:mi/><mml:mo>∙</mml:mo></mml:math></inline-formula>100 for a window from the TSS to 10 [kbp] downstream, excluding the first 200 [bp] (<bold>C</bold>). A red line indicates the median response (58%).</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-29736-fig1-v2"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.29736.004</object-id><label>Figure 1—figure supplement 1.</label><caption><title>Model of a paused polymerase positioned up to around 50 bp downstream of the TSS.</title><p>Modeling shows that paused Pol II (silver, right) positioned 50 bp downstream of the transcription start site (TSS) allows for formation of the Pol II initiation complex (different colors, left). Shorter distances between the active sites of paused and initiating Pol II are predicted to lead to steric clashes. Modeling is based on the latest structural information (Mediator EMD-8307 [<xref ref-type="bibr" rid="bib44">Robinson et al., 2016</xref>], TFIID EMD-3305 [<xref ref-type="bibr" rid="bib31">Louder et al., 2016</xref>], TFIIH EMD EMD-3307 [<xref ref-type="bibr" rid="bib17">He et al., 2016</xref>], closed complex PDB-code 5FZ5 [<xref ref-type="bibr" rid="bib41">Plaschka et al., 2016</xref>], EC PDB-code 1WCM [<xref ref-type="bibr" rid="bib23">Kettenberger et al., 2004</xref>]).</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-29736-fig1-figsupp1-v2"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.29736.005</object-id><label>Figure 1—figure supplement 2.</label><caption><title>CRISPR-Cas9 directed engineering, cellular and biochemical characterization of CDK9<sup>as</sup> Raji B cell line.</title><p>(<bold>A</bold>) BstUI restriction enzyme recognition site used for screening is indicated in the HDR template sequence (highlighted in red). Agarose gels of screening PCRs followed by restriction digest with BstUI of wild type (wt) and CDK9<sup>as</sup> (as) Raji B cell line. (<bold>B</bold>) Validation of CDK9<sup>as</sup> Raji B cell line by sequencing. (<bold>C</bold>) Log fold change upon 1-NA-PP1 treatment (5 µM for 15 min) versus the normalized mean read count across replicates and conditions for wild type Raji B cells (left panel) and CDK9<sup>as</sup> Raji B cells (right panel). Significantly up- or downregulated TUs (adjusted p-value&lt;0.01) are marked in red. (<bold>D</bold>) Wild type and CDK9<sup>as</sup> Raji B cells were treated with 10 µM of 1-NA-PP1 for 15 min or 2 hr. DMSO was used as control. Stable CDK9 protein levels were detected by Western blotting (Materials and methods). α-Tubulin was used as loading control. (<bold>E</bold>) Cell proliferation at increasing 1-NA-PP1 inhibitor concentrations (log scale) was determined using a colorimetric assay based on MTS metabolization (Materials and methods). Cell proliferation of CDK9<sup>as</sup> Raji B cells was dramatically reduced by &gt;50% when 1-NA-PP1 concentrations of 5 µM (indicated with dashed red line) or higher were used, whereas wild type Raji B cells were largely unaffected. Error bars indicate the standard deviation (n = 4).</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-29736-fig1-figsupp2-v2"/></fig></fig-group><p>To determine the relative response of genes to CDK9 inhibition, we calculated response ratios for those transcribed units (TUs, Materials and methods) that synthesized RNA, harbored a single TSS, and exceeded 10 kbp in length (2,538 TUs). The response ratio of TUs varied between 0% to 100% (fully responding TUs) with a median of 58% (<xref ref-type="fig" rid="fig1">Figure 1C–E</xref>). A remaining TT-seq signal in the response window likely reflects the proportion of polymerases that move to productive elongation without CDK9 kinase activity, but we cannot exclude that it stems from incomplete CDK9 inhibition. However, based on the assumption that the inhibitor is evenly distributed across cells and within, the portion of CDK9 that has not been fully inhibited must be very low.</p></sec><sec id="s2-3"><title>Pol II elongation velocity is gene-specific</title><p>The width of the response window differs between TUs (<xref ref-type="fig" rid="fig1">Figure 1D</xref>) and informs on Pol II elongation velocity (Materials and methods). The average width of the response window was 23 kbp, and thus the average elongation velocity was 2.3 kbp/min (<xref ref-type="fig" rid="fig2">Figure 2A–B</xref>), which agrees with previous estimates (<xref ref-type="bibr" rid="bib15">Fuchs et al., 2014</xref>; <xref ref-type="bibr" rid="bib22">Jonkers et al., 2014</xref>; <xref ref-type="bibr" rid="bib48">Saponaro et al., 2014</xref>; <xref ref-type="bibr" rid="bib55">Veloso et al., 2014</xref>). Gene-specific elongation velocities (<xref ref-type="fig" rid="fig2">Figure 2C</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A–B</xref>) were significantly higher in TUs with longer first introns (<xref ref-type="fig" rid="fig2">Figure 2D</xref>, Wilcoxon rank sum test, p-value&lt;1.916·10<sup>−11</sup>), consistent with faster transcription of introns (<xref ref-type="bibr" rid="bib22">Jonkers et al., 2014</xref>). Elongation velocity correlated positively with nucleosome density, and negatively with the stability of the DNA-RNA hybrid, CpG density and topoisomerase occupancy (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C</xref>).</p><fig-group><fig id="fig2" position="float"><object-id pub-id-type="doi">10.7554/eLife.29736.006</object-id><label>Figure 2.</label><caption><title>Pol II elongation velocity.</title><p>(<bold>A</bold>) Schematic representation of observed response window of TT-seq signal with CDK9<sup>as</sup> inhibitor (red) or control (black) for TUs of three different length classes (short TUs &lt; 25 [kbp], medium-length TUs 25–50 [kbp] and long TUs &gt; 100 [kbp]). (<bold>B</bold>) Scatter plot of the ratio of transcribed bases (CDK9<sup>as</sup> inhibited/control) (Materials and methods) against the length of the TUs in nucleotides [kbp] revealed that the schematic representation in (<bold>A</bold>) holds true for 2443 investigated TUs (Materials and methods). Modeling of the observed relation allows estimation of a robust average elongation velocity of 2.3 [kbp/min] (solid black line, Materials and methods). (<bold>C</bold>) Distribution of gene-wise elongation velocity depicted as a histogram (mean 2.7 [kbp/min], median 2.4 [kbp/min]). (<bold>D</bold>) Distributions of elongation velocity [kbp/min] depicted for 513 TUs with short first intron (&lt;50% quantile, left) and 514 TUs with long first intron (&gt;50% quantile, right).</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-29736-fig2-v2"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.29736.007</object-id><label>Figure 2—figure supplement 1.</label><caption><title>Example genome browser views of TT-seq signals in CDK9<sup>as</sup> cells with estimated response window and genomic features correlating with elongation velocity.</title><p>(<bold>A</bold>) YWHAQ gene locus (47,042 [bp]) on chromosome 2. The upper panel shows TT-seq signal with CDK9<sup>as</sup> inhibitor (red) and control (black). Grey box depicts transcript body from transcription start site (TSS, black arrow) to polyA site (pA). Lower panel shows the difference of TT-seq signal (control – CDK9<sup>as</sup> inhibited in blue). Black rectangle depicts the estimated response window according to elongation velocity estimate (Materials and methods). (<bold>B</bold>) HEATR3 gene locus (40,446 [bp]) on chromosome 16 depicted as in (<bold>A</bold>). (<bold>C</bold>) Color encoded Spearman correlation coefficients (color encoded, −0.45 in blue to 0.21 in red) of elongation velocity [kbp/min] against genomic features and measures of transcriptional context (Materials and methods, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>).</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-29736-fig2-figsupp1-v2"/></fig></fig-group></sec><sec id="s2-4"><title>Promoter-proximal pausing occurs at sequences that give rise to weak DNA-RNA hybrids</title><p>To study the kinetics of CDK9-dependent Pol II pause release, we generated mNET-seq data that map the RNA 3’-end of engaged Pol II and extracted the position of paused polymerases (Materials and methods). mNET-seq data were highly reproducible (Spearman correlation coefficient 0.93). Of the above TUs, 2135 (84 %) showed mNET-seq signal peaks above background (Materials and methods). The called pause sites were distributed around a maximum located ~84 bp downstream of the TSS (<xref ref-type="fig" rid="fig3">Figure 3A</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>). At these sites we detected an enrichment for G/C-C/G dinucleotides (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B</xref>) with a strongly conserved cytosine at the RNA 3’-end (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). We also observed a minimum of the predicted melting temperature of the DNA-RNA hybrid (Materials and methods) immediately downstream of the pause site (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). A weak DNA-RNA hybrid in the active center of Pol II is known to destabilize the elongation complex (<xref ref-type="bibr" rid="bib24">Kireeva et al., 2000</xref>), and could be a major determinant for establishing the paused state.</p><fig-group><fig id="fig3" position="float"><object-id pub-id-type="doi">10.7554/eLife.29736.008</object-id><label>Figure 3.</label><caption><title>Distribution and sequence of promoter-proximal pause sites.</title><p>(<bold>A</bold>) Distribution of pause site distance from the TSS for 2135 investigated TUs depicted as a histogram (mean 128 [bp], median 112 [bp], mode 84 [bp]). Two biological replicates were averaged. (<bold>B</bold>) Position weight matrix (PWM) logo representation of bases at positions –10 to +10 [bp] around the pause site (position 0). (<bold>C</bold>) Mean melting temperature of the DNA-RNA and DNA-DNA hybrid aligned at the TSS and the pause site (signal between the TSS and the pause site is scaled to common length of 100 [bp]). Shaded areas around the average signal (solid lines) indicate confidence intervals.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-29736-fig3-v2"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.29736.009</object-id><label>Figure 3—figure supplement 1.</label><caption><title>Features of underlying DNA sequence around promoter-proximal pause sites.</title><p>(<bold>A</bold>) Distributions of pause site depicted as densities for TUs with a response ratio &gt;75% quantile (574 TUs, red) and TUs with a response ratio &lt;25% quantile (469 TUs, black). (<bold>B</bold>) Plot showing the top 5 enriched 2-mers found by comparing the frequency of all possible 2-mers in a window of ±10 bp around the estimated pause site for fixed positions. Testing was done via Fisher’s exact test against the (background) frequency of the respective 2-mer obtained from a window of the same size shifted 500 bp downstream. The respective p-values and odd-ratios are given in the left and right panel.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-29736-fig3-figsupp1-v2"/></fig></fig-group></sec><sec id="s2-5"><title>Multi-omics analysis provides pause duration <italic>d</italic> and initiation frequency <italic>I</italic></title><p>To quantify pausing, we defined the pause duration <italic>d</italic> as the time a polymerase needs to pass through a 200 bp ‘pause window’ located ±100 bp around the pause site. The pause duration <italic>d</italic> can now be derived from a combination of mNET-seq and TT-seq data. In particular, the mNET-seq signal corresponds to the number of polymerases in the pause window, which is determined by <italic>d</italic> and by the initiation frequency <italic>I</italic> (<xref ref-type="fig" rid="fig4">Figure 4A</xref>) (<xref ref-type="bibr" rid="bib13">Ehrensberger et al., 2013</xref>). Thus, <italic>d</italic> is proportional to the ratio of the mNET-seq signal over <italic>I.</italic> To calculate <italic>I</italic> we integrated TT-seq signals over exons, excluding the first exon (Materials and methods). This provides the ‘productive initiation frequency’, that is the number of polymerases that initiate and successfully exit from the pause window. We use the term ‘productive’ because we do not know whether there is a small fraction of polymerases terminating within the pause window. Finally, to derive absolute values of <italic>d</italic>, we scaled the reciprocal of <italic>d</italic> (the elongation velocity in the pause window) according to the elongation velocity obtained from CDK9 inhibition (Materials and methods).</p><fig-group><fig id="fig4" position="float"><object-id pub-id-type="doi">10.7554/eLife.29736.010</object-id><label>Figure 4.</label><caption><title>Pol II pausing generally limits transcription initiation (‘pause-initiation limit’).</title><p>(<bold>A</bold>) Schematic representation of polymerase flow in the promoter-proximal region. The mNET-seq signal (top) is the ratio of the initiation frequency <italic>I</italic> over the elongation velocity <italic>v</italic>. The TT-seq signal (bottom) corresponds to initiation frequency <italic>I.</italic> Thus, <italic>v</italic> can be derived from the ratio of the TT-seq over the mNET-seq signal, and the reciprocal of <italic>v</italic> in the pause window corresponds to the pause duration <italic>d</italic>. (<bold>B</bold>) Distributions of gene-wise pause duration <italic>d</italic> [min] for TUs with a CDK9 response ratio &gt;75% quantile (574 TUs) and TUs with a response ratio &lt;25% quantile (469 TUs). (<bold>C</bold>) Distributions of gene-wise initiation frequency <italic>I</italic> [cell<sup>−1</sup>min<sup>−1</sup>] for TUs with a CDK9 response ratio &gt;75% quantile (635 TUs) and TUs with a response ratio &lt;25% quantile (635 TUs). (<bold>D</bold>) Scatter plot between the initiation frequency <italic>I</italic> [cell<sup>−1</sup>min<sup>−1</sup>] and the pause duration <italic>d</italic> [min] for 2135 common TUs with color-coded density estimation. The grey shaded area depicts impossible combinations of <italic>I</italic> and <italic>d</italic> according to published kinetic theory (<xref ref-type="bibr" rid="bib13">Ehrensberger et al., 2013</xref>) and assuming that steric hindrance occurs below a distance of 50 [bp] between the active sites of the initiating Pol II and the paused Pol II.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-29736-fig4-v2"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.29736.011</object-id><label>Figure 4—figure supplement 1.</label><caption><title>A longer pause duration but not promoter-proximal termination of polymerase leads to shortage of labeled RNA in the region between TSS and pause site.</title><p>(<bold>A</bold>) Simulation of labeled RNA fragments synthesized in 5 min labeling duration (TT-seq fragments depicted for polymerases with a distance corresponding to 40 s of elongation, middle panel) for a pause site 80 bp downstream of the TSS with a given elongation velocity profile [bp min<sup>−1</sup>] comprising a pause duration of 1 min (upper panel) and a initiation frequency of 0.5 [cell<sup>−1</sup>min<sup>−1</sup>]. Lower panel shows the resulting TT-seq coverage. Shorter fragments have a higher probability to escape labeled RNA purification and can not be recovered fully. (<bold>B</bold>) Simulation of labeled RNA fragments as in (<bold>A</bold>) with two times the initiation frequency (1 [cell<sup>−1</sup>min<sup>−1</sup>]) and a promoter-proximal termination of every second polymerase. The resulting TT-seq coverage (lower panel) shows less effect (higher coverage) upstream of the pause site. For reasons of simplicity the promoter-proximal termination of every second polymerase is modeled by overlaying two simulation instances with an initiation frequency of 0.5 [cell<sup>−1</sup>min<sup>−1</sup>]. One as in (<bold>A</bold>) and one with a constantly terminating polymerase. Note that polymerases that terminate in the pause window do not contribute signal to the region downstream of the pause site. (<bold>C</bold>) Simulation of labeled RNA fragments as in (<bold>A</bold>) with a pause duration of 2 min (upper panel) leading to a greater shortage of labeled RNA in the region between the TSS and the pause site. (<bold>D</bold>) Schematic representation of coverage ratio calculation for real TT-seq coverage. (<bold>E</bold>) Distributions of gene-wise uridine content in the region between the TSS and the pause site for TUs with a response ratio &gt;75% quantile (603 TUs) and TUs with a response ratio &lt;25% quantile (527 TUs). (<bold>F</bold>) Distributions of gene-wise mean real TT-seq signal in the region between the TSS and the pause site normalized to initiation frequency for subsets as in (<bold>E</bold>).</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-29736-fig4-figsupp1-v2"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.29736.012</object-id><label>Figure 4—figure supplement 2.</label><caption><title>Verification of anti-correlation between initiation frequency <italic>I</italic> and pause duration <italic>d</italic> including ‘pause-initiation limit’.</title><p>(<bold>A</bold>) Scatter plot comparing the initiation frequency [cell<sup>−1</sup>min<sup>−1</sup>] against the pause duration [min] for 2135 common TUs with color encoding according to mNETseq signal strength (weak in white to strong in blue). The grey shaded area depicts impossible combinations of <italic>I</italic> and <italic>d</italic> according to published kinetic theory (<xref ref-type="bibr" rid="bib13">Ehrensberger et al., 2013</xref>) and assuming that steric hindrance occurs below a distance of 50 bp between the active sites of the initiating Pol II and the paused Pol II. (<bold>B</bold>) Schematic representation of polymerase flow in the promoter-proximal region. The number of polymerases in a region of interest (mNET-seq signal, top) corresponds to the average elongation velocity <italic>v</italic> in that region. The width of the response window (TT-seq signal, bottom) informs on Pol II elongation velocity <italic>v.</italic> The pause duration <inline-formula><mml:math id="inf2"><mml:mover accent="true"><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:math></inline-formula> can be derived (without the initiation frequency <italic>I</italic>) as the reciprocal of <italic>v</italic> in the pause window. The elongation velocity <italic>v</italic> in the pause window relates directly to <italic>v</italic> in the response window which can be adjusted to the elongation velocity obtained from CDK9 inhibition (Materials and methods). (<bold>C</bold>) Scatter plot revealing an anti-correlation between the initiation frequency <italic>I</italic> [cell<sup>−1</sup>min<sup>−1</sup>] and the pause duration <inline-formula><mml:math id="inf3"><mml:mover accent="true"><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:math></inline-formula> [min] for 974 common TUs with color-coded density estimation (Spearman correlation coefficient −0.3). The grey shaded area depicts impossible combinations of <italic>I</italic> and <inline-formula><mml:math id="inf4"><mml:mover accent="true"><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:math></inline-formula> according to published kinetic theory (<xref ref-type="bibr" rid="bib13">Ehrensberger et al., 2013</xref>). (<bold>D</bold>) Density showing the spearman correlation coefficient of pause duration <inline-formula><mml:math id="inf5"><mml:mover accent="true"><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:math></inline-formula> and initiation frequency I for repeated randomly shuffled mNET-seq signal assignment to TUs. Original spearman correlation coefficient is indicated with a red line. (<bold>E</bold>) Distributions of gene-wise pause duration <inline-formula><mml:math id="inf6"><mml:mover accent="true"><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:math></inline-formula> [min] for TUs with a CDK9 response ratio &gt;75% quantile (155 TUs) and TUs with a response ratio &lt;25% quantile (271 TUs). (<bold>F</bold>) Density showing the number of impossible combinations of pause duration <inline-formula><mml:math id="inf7"><mml:mover accent="true"><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:math></inline-formula> and initiation frequency <italic>I</italic> (above pause-initiation limit) for repeated randomly shuffled mNET-seq signal assignment to TUs. Original observation is indicated with a red line.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-29736-fig4-figsupp2-v2"/></fig></fig-group><p>We obtained a mean productive initiation frequency of 2.7 polymerases cell<sup>−1</sup>min<sup>−1</sup>, and pause durations in the range of minutes, with strong variations between TUs. The pause durations are generally consistent with reported half-lives of paused Pol II in mouse (<xref ref-type="bibr" rid="bib22">Jonkers et al., 2014</xref>) and Drosophila cells (<xref ref-type="bibr" rid="bib5">Buckley et al., 2014</xref>; <xref ref-type="bibr" rid="bib19">Henriques et al., 2013</xref>) but slightly shorter. Pause durations were also consistent with kinetic modeling of TT-seq data alone. At TUs with long pause durations we observed less labeled RNA in the short region between the TSS and the pause site (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). This confirms that indeed initiation frequencies are altered. It also indicates that the fraction of Pol II enzymes that terminate within the pause window is low, in agreement with previous findings (<xref ref-type="bibr" rid="bib19">Henriques et al., 2013</xref>). For strongly CDK9-responding TUs, we obtained a significantly longer pause duration (Wilcoxon rank sum test, p-value&lt;10<sup>−12</sup>) and lower initiation frequencies (<xref ref-type="fig" rid="fig4">Figure 4B–C</xref>).</p></sec><sec id="s2-6"><title>Human genes have a ‘pause-initiation limit’</title><p>These results prompted us to ask whether the pause duration is generally related to the initiation frequency. We indeed found a robust anti-correlation between <italic>I</italic> and <italic>d</italic> in normally growing cells, and an upper boundary for combinations of <italic>I</italic> and <italic>d</italic> which we call ‘pause-initiation limit’. (<xref ref-type="fig" rid="fig4">Figure 4D</xref>, <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2A</xref>). Thus, genes with shorter pausing show higher initiation frequencies and more RNA synthesis. This fundamental relationship can be verified by calculating the pause duration <inline-formula><mml:math id="inf8"><mml:mi>d</mml:mi> <mml:mi/></mml:math></inline-formula> without the initiation frequency <italic>I,</italic> <inline-formula><mml:math id="inf9"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mrow><mml:mover><mml:mi>d</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover></mml:mrow></mml:mrow></mml:mstyle></mml:math></inline-formula> (Materials and methods, <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2B–C,E</xref>). Repeated random shuffling of mNET-seq signal assignment to TUs abolishes the correlation between <inline-formula><mml:math id="inf10"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mrow><mml:mover><mml:mi>d</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover></mml:mrow></mml:mrow></mml:mstyle></mml:math></inline-formula> and <italic>I</italic> (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2D</xref>). It also shows that the observation of impossible combinations of pause duration <inline-formula><mml:math id="inf11"><mml:mover accent="true"><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:math></inline-formula> and initiation frequency <italic>I</italic> (points above ‘pause-initiation limit’) are minimal (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2F</xref>). In conclusion, independent mNET-seq and TT-seq data led to independent measures of pause duration and productive initiation frequency for each gene, which were then observed to be globally anti-correlated.</p><p>These findings now allowed us to test directly whether longer pause durations lead to lower initiation frequencies, by analyzing TT-seq data after CDK9 inhibition. CDK9 inhibition resulted in significantly reduced labeled RNA in the short region between the TSS and the pause site (Wilcoxon rank sum test, p-value&lt;10<sup>−16</sup>) (<xref ref-type="fig" rid="fig5">Figure 5A–B</xref>). Productive initiation frequencies were significantly downregulated after CDK9 inhibition (Wilcoxon rank sum test, p-value&lt;10<sup>−16</sup>) (<xref ref-type="fig" rid="fig5">Figure 5C</xref>). Because CDK9 specifically targets paused Pol II, and not initiating polymerase, these results show that pausing limits initiation, and not the other way around. Thus, human genes have a ‘pause-initiation limit’.</p><fig id="fig5" position="float"><object-id pub-id-type="doi">10.7554/eLife.29736.013</object-id><label>Figure 5.</label><caption><title>Increasing Pol II pause duration decreases the frequency of transcription initiation.</title><p>(<bold>A</bold>) Schematic representation of observed decrease in TT-seq signal upon CDK9 inhibition, upstream and downstream of the pause site. (<bold>B</bold>) Distributions of gene-wise mean TT-seq signals in the region between the TSS and the pause site, before (control) and after CDK9 inhibition, normalized to the initiation frequency before CDK9 inhibition. (<bold>C</bold>) Distributions of gene-wise initiation frequencies before (control) and after CDK9 inhibition.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-29736-fig5-v2"/></fig><p>To monitor the occupancy of engaged Pol II we generated mNET-seq data before and after CDK9 inhibition (Materials and methods). CDK9 inhibition resulted in increased mNET-seq signal at the beginning of genes and decreased signal in the gene body, indicating that less Pol II was released from the pause site (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). Indeed, calculation of pause durations from mNET-seq and TT-seq data after CDK9 inhibition showed that Pol II resides significantly longer at the pause site after CDK9 inhibition (Wilcoxon rank sum test, p-value&lt;10<sup>−16</sup>) (<xref ref-type="fig" rid="fig6">Figure 6B</xref>). Taken together, CDK9 inhibition increases the pause duration and decreases the initiation frequency at human genes (<xref ref-type="fig" rid="fig6">Figure 6C–D</xref>).</p><fig id="fig6" position="float"><object-id pub-id-type="doi">10.7554/eLife.29736.014</object-id><label>Figure 6.</label><caption><title>CDK9 inhibition leads to increased pause duration.</title><p>(<bold>A</bold>) Metagene analysis comparing the average mNET-seq signal before and after CDK9 inhibition. Two biological replicates were averaged. The mNET-seq coverage was averaged for 2538 investigated TUs (Materials and methods). TUs were aligned with their TSS. Shaded areas around the average signal (solid lines) indicate confidentiality intervals (Materials and methods). (<bold>B</bold>) Distributions of gene-wise pause duration <italic>d</italic> [min] before (control) and after CDK9 inhibition. (<bold>C</bold>) Scatter plot between the initiation frequency <italic>I</italic> [cell<sup>−1</sup>min<sup>−1</sup>] and the pause duration <italic>d</italic> [min] after CDK9 inhibition for 2135 common TUs with color-coded density estimation. The grey shaded area depicts impossible combinations of <italic>I</italic> and <italic>d</italic> (<xref ref-type="bibr" rid="bib13">Ehrensberger et al., 2013</xref>) assuming that steric hindrance occurs below a distance of 50 [bp] between the active sites of the initiating Pol II and the paused Pol II. (<bold>D</bold>) Schematic of changes in pause duration (Δ<italic>d</italic>) and initiation frequency (Δ<italic>I</italic>) upon CDK9 inhibition. As a consequence, data points in panel (<bold>D</bold>) are moved to the left and upwards.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-29736-fig6-v2"/></fig></sec><sec id="s2-7"><title>Determinants of promoter-proximal pausing</title><p>To investigate possible reasons for polymerase pausing and its consequences, we compared different properties of TUs with long and short pause durations. For the 5’-region of TUs with longer pause durations, the transcript adopts more RNA secondary structure in vivo and in silico (Wilcoxon rank sum test, p-value&lt;10<sup>−16</sup>) (<xref ref-type="fig" rid="fig7">Figure 7A</xref>, <xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1A</xref>) (<xref ref-type="bibr" rid="bib46">Rouskin et al., 2014</xref>). TUs with longer pause durations were also enriched for hyper-methylated CpG islands (<xref ref-type="bibr" rid="bib14">ENCODE Project Consortium, 2012</xref>) upstream of the pause site (<xref ref-type="fig" rid="fig7">Figure 7B</xref>), consistent with a previous report (<xref ref-type="bibr" rid="bib18">Hendrix et al., 2008</xref>). Comparison of strongly and weakly CDK9-responding TUs around the pause site showed that TUs that responded strongly to CDK9 inhibition showed a higher tendency to establish long-range chromatin interactions (<xref ref-type="fig" rid="fig7">Figure 7C</xref>) as observed by Hi-C (<xref ref-type="bibr" rid="bib32">Ma et al., 2015</xref>). This is consistent with the idea that interactions of an enhancer with its target promoter can stimulate Pol II pause release (<xref ref-type="bibr" rid="bib16">Ghavi-Helm et al., 2014</xref>; <xref ref-type="bibr" rid="bib42">Rahl et al., 2010</xref>). This tendency however seems to be independent of the pause duration as comparing TUs with long and short pause durations leads to no observable difference in Hi-C signal.</p><fig-group><fig id="fig7" position="float"><object-id pub-id-type="doi">10.7554/eLife.29736.015</object-id><label>Figure 7.</label><caption><title>Determinants of CDK9-dependent promoter-proximal pausing.</title><p>(<bold>A</bold>) Distribution of gene-wise mean in vivo DMS-seq signals (detecting RNA secondary structure) for a window between −65 and −15 [bp] upstream of the pause site for TUs with long pause durations (pause duration &gt;75% quantile, 534 TUs) and with short pause durations (pause duration &lt;25% quantile, 534 TUs) normalized to denatured DMS-seq coverage (Materials and methods). (<bold>B</bold>) Metagene analysis comparing the average Bisulfite-seq signal (detecting methylated DNA) for subsets as in (<bold>A</bold>) aligned at the pause site (red, long pause duration, and black, short pause duration). Shaded areas around the average signal (solid lines) indicate confidence intervals. (<bold>C</bold>) Metagene analysis comparing the average Hi-C signal (detecting long-range chromatin interactions) for strongly CDK9-responding TUs (red, response ratio &gt;75% quantile, 552 TUs) and weakly CDK9-responding TUs (black, response ratio &lt;25% quantile, 440 TUs) aligned at the pause site. Shaded areas around the average signal (solid lines) indicate confidence intervals (Materials and methods, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>).</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-29736-fig7-v2"/></fig><fig id="fig7s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.29736.016</object-id><label>Figure 7—figure supplement 1.</label><caption><title>Features of promoter-proximal pausing.</title><p>(<bold>A</bold>) Distributions of gene-wise mean minimum free energy (Materials and methods) for a window of [−15,–65] bp upstream of the pause site for TUs with long pause durations (pause duration &gt;75% quantile, 534 TUs) and TUs with short pause durations (pause duration &lt;25% quantile, 534 TUs). (<bold>B</bold>) Heatmap showing the pairwise Spearman correlation (color encoded, −0.12 in blue to 0.15 in red) using ChIP measurements of Pol II phospho-isoforms S2P, S5P, S7P and T1P in the pause window against the pause duration in three different variants: ChIP measurements normalized to productive initiation rate (initiation rate), normalized to total Pol II (Pol II), raw signal (raw). (<bold>C</bold>) Heatmap as in (<bold>B</bold>) using ChIP measurements of CDK9, NELFe and Brd4 (color encoded, −0.19 in blue to 0.22 in red) (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>).</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-29736-fig7-figsupp1-v2"/></fig></fig-group><p>Finally, we investigated which factors preferentially occupy pause windows with longer pause durations. This is now possible because ChIP-seq signals can be normalized with the productive initiation frequency. Without such normalization, ChIP-seq derived factor occupancies are artificially high in pause windows with long pause durations (<xref ref-type="bibr" rid="bib13">Ehrensberger et al., 2013</xref>). Correlation of such normalized ChIP-seq signals in the pause window with pause durations (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1B–C</xref>) resulted in a positive correlation for Pol II phosphorylation at sites that are associated with elongation, and also for NELF-E, CDK9, and Brd4, which are all factors involved in Pol II pausing and release.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Taken together, our results show that Pol II pausing can control transcription initiation and demonstrate the central role of CDK9 in controlling pause duration and thereby the productive initiation frequency. Our results have implications for understanding gene regulation. Genes that show initiation frequencies below the pause-initiation limit may be activated by increasing the initiation frequency without changing pause duration. However, activation of genes that are transcribed at the pause-initiation limit requires a decrease in pause duration, that is stimulation of pause release, to enable higher initiation frequencies. We suggest that pause-controlled initiation evolved because mutations in the promoter-proximal region can change pause duration, and thereby limit initiation, but do not compromise a high initiation capacity of the core promoter around the TSS. This may have enabled the evolution of genes that remain highly inducible but can be efficiently downregulated.</p><p>After our work had been completed, a publication appeared that concluded that polymerase pausing inhibits new transcription initiation (<xref ref-type="bibr" rid="bib51">Shao and Zeitlinger, 2017</xref>). The conclusion in this paper is consistent with our general finding of an interdependency of Pol II pausing and transcription initiation, but the two studies differ in three aspects. First, we used human cells whereas the published work was conducted in Drosophila cells. Second, our work uses a multi-omics approach to enable a kinetic description, whereas the published work is based on changes in factor occupancy. Third, we selectively inhibited CDK9 using CRISPR-Cas9-based engineering and chemical biology, whereas the published work used small molecule inhibitors that may target multiple kinases. Despite these differences, the general conclusion that promoter-proximal pausing of Pol II sets a limit to the frequency of transcription initiation holds for both human and Drosophila cells and is likely a general feature of metazoan gene regulation.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Key resources table</title><table-wrap id="inlinetable1" position="anchor"><table frame="hsides" rules="groups"><thead><tr><th valign="top">Reagent type (species) <break/>or resource</th><th valign="top">Designation</th><th valign="top">Source or reference</th><th valign="top">Identifiers</th><th valign="top">Additional information</th></tr></thead><tbody><tr><td valign="top">cell line (Homo sapiens; male)</td><td valign="top">Raji B lymphocyte cells (wild type)</td><td valign="top">DSMZ</td><td valign="top">DSMZ Cat# ACC-319; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/CVCL_0511">CVCL_0511</ext-link></td><td valign="top"/></tr><tr><td valign="top">cell line (Homo sapiens; male)</td><td valign="top">Raji B lymphocyte cells (CDK9<sup>as</sup>)</td><td valign="top">This paper</td><td valign="top"/><td valign="top">Raji B cells were obtained from DSMZ Cat# ACC-319, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/CVCL_0511">CVCL_0511</ext-link>. Homozygous mutation of F103 at the CDK9 gene loci in Raji B cells was performed using the CRISPR-Cas9 system.</td></tr><tr><td valign="top">antibody</td><td valign="top">anti-CDK9</td><td valign="top">Santa Cruz, Dallas, TX USA</td><td valign="top">sc-484</td><td valign="top"/></tr><tr><td valign="top">antibody</td><td valign="top">anti-alpha-tubulin</td><td valign="top">Sigma-Aldrich, St. Louis, MO USA</td><td valign="top">DM1A</td><td valign="top"/></tr><tr><td valign="top">antibody</td><td valign="top">anti-Pol II (total, unphos + phos)</td><td valign="top">BIOZOL, Eching, Germany</td><td valign="top">MABI0601</td><td valign="top"/></tr><tr><td valign="top">commercial assay or kit</td><td valign="top">CellTiter 96 AQueous One Solution Cell Proliferation Assay (MTS)</td><td valign="top">Promega, Madison, WI USA</td><td valign="top">G3582</td><td valign="top"/></tr><tr><td valign="top">commercial assay or kit</td><td valign="top">Plasmo Test Mycoplasma Detection Kit</td><td valign="top">InvivoGen, San Diego, CA USA</td><td valign="top">rep-pt1</td><td valign="top"/></tr><tr><td valign="top">commercial assay or kit</td><td valign="top">Ovation Universal RNA-Seq System</td><td valign="top">NuGEN, Leek, The Netherlands</td><td valign="top">0343–32</td><td valign="top"/></tr><tr><td valign="top">commercial assay or kit</td><td valign="top">TruSeq Small RNA Library Prep Kit</td><td valign="top">Illumina, Massachusetts USA</td><td valign="top">RS-200–0012</td><td valign="top"/></tr><tr><td valign="top">chemical compound, drug</td><td valign="top">CDK9as inhibitor; 1-NA-PP1</td><td valign="top">Calbiochem, EMD Millipore, Danvers, MA USA</td><td valign="top">529579</td><td valign="top">CAS 221243-82-9</td></tr><tr><td valign="top">chemical compound, drug</td><td valign="top">Solvent control; DMSO</td><td valign="top">Sigma-Aldrich, St. Louis, MO USA</td><td valign="top">D8418</td><td valign="top"/></tr><tr><td valign="top">chemical compound, drug</td><td valign="top">4-thiouracil (4sU)</td><td valign="top">Sigma-Aldrich, St. Louis, MO USA</td><td valign="top">T4509</td><td valign="top"/></tr><tr><td valign="top">chemical compound, drug</td><td valign="top">empigen BB detergent</td><td valign="top">Sigma-Aldrich, St. Louis, MO USA</td><td valign="top">30326</td><td valign="top"/></tr></tbody></table></table-wrap></sec><sec id="s4-2"><title>Cell lines and cell culture</title><p>Raji B cells were obtained from DSMZ (DSMZ no.: ACC 319; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/CVCL_0511">CVCL_0511</ext-link>). CDK9<sup>as</sup> Raji B cells were generated in this study by CRISPR-Cas9-based engineering of Raji B cells obtained from DSMZ (DSMZ no.: ACC 319; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/CVCL_0511">CVCL_0511</ext-link>). Raji B cells and CDK9<sup>as</sup> Raji B cells were grown in RPMI 1640 medium (Thermo Fisher Scientific, Waltham, MA USA) supplemented with 10% foetal calf serum (bio-sell, Nürnberg, Germany), 100 U/mL penicillin and 100 µg/mL streptomycin (Thermo Fisher Scientific, Waltham, MA USA), and 2 mM L-glutamine (Thermo Fisher Scientific, Waltham, MA USA) at 37°C and 5% CO<sub>2</sub>. Cells were verified to be free of mycoplasma contamination using Plasmo Test Mycoplasma Detection Kit (InvivoGen, San Diego, CA USA).</p></sec><sec id="s4-3"><title>Generation of human CDK9<sup>as</sup>Raji B cell line</title><p>CDK9<sup>as</sup> contains a point mutation of the so-called gatekeeper residue that enables the kinase active site to accept bulky ATP analogs (1-NA-PP1) (4-Amino-1-tert-butyl-3-(1ʹ-naphthyl)pyrazolo[3,4-d]pyrimidine). To identify the gatekeeper residue (<xref ref-type="bibr" rid="bib29">Lopez et al., 2014</xref>), the amino acid sequence of the human CDK9 kinase (UniProt, P50750-1) was aligned with sequences of previously characterized kinases carrying analog sensitive mutations. Multiple sequence alignment was performed with the web tool Clustal Omega 1.2.4 (<xref ref-type="bibr" rid="bib52">Sievers et al., 2011</xref>). For the canonical isoform of CDK9, phenylalanine (F) 103 was identified as the gatekeeper residue and selected for mutation to alanine (A). Mutation of F103 at the CDK9 gene loci in Raji B cells was performed using the CRISPR-Cas9 system (<xref ref-type="bibr" rid="bib12">Doudna and Charpentier, 2014</xref>; <xref ref-type="bibr" rid="bib20">Hsu et al., 2014</xref>) as described (<xref ref-type="bibr" rid="bib36">Mulholland et al., 2015</xref>) with minor modifications. Briefly, the single guide RNA (sgRNA) for editing CDK9 was designed by using the web tool Optimized CRISPR design (<ext-link ext-link-type="uri" xlink:href="http://crispr.mit.edu/">http://crispr.mit.edu/</ext-link>), and was incorporated to pSpCas9(BB)−2A-GFP (PX458) vector by BpiI restriction sites (Addgene plasmid # 48138) (<xref ref-type="bibr" rid="bib43">Ran et al., 2013</xref>). For nucleotide replacement (gttc to cgcg), 200 nt single-stranded DNA oligonucleotides (ssODNs) were synthesized by Integrated DNA Technologies (IDT, Leuven, Belgium) and used as homology-directed repair (HDR) template. A BstUI cutting site was incorporated into the HDR template for screening. The vector and HDR template were introduced into human Raji B cells using Amaxa Mouse ES Cell Nucleofector Kit (Lonza, Basel, Switzerland) according to the manufacturer’s instructions. Two days after transfection, GFP positive cells were single cell sorted into 96 well plates using FACS Aria II instrument (Becton Dickinson, Franklin Lakes, NJ USA). After two weeks, individual colonies were expanded for genomic DNA isolation. The mutant lines were validated by PCR using respective primers, BstUI digestion (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2A</xref>) and DNA sequencing (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2B</xref>).</p><p>HDR template (A103 is underlined, BstUI cutting site in small letters):</p><p>AAAGTGTGTTGGGTGTGGTTTTCTTGACTTTTTCTTCTTTCTATTCCTGCCTCAGCTTCCCCCTATAACCGCTGCAAGGGTAGTATATACCTGGTc<underline>gcg</underline>GACTTCTGCGAGCATGACCTTGCTGGGCTGTTGAGCAATGTTTTGGTCAAGTTCACGCTGTCTGAGATCAAGAGGGTGATGCAGATGCTGCTTAACGGCCT</p><p>Primers for sgRNA generation and screening:</p><p>CDK9-sgRNA-F: 5’-CACCGGCTCGCAGAAGTCGAACACC-3’</p><p>CDK9-sgRNA-R: 5’-AAACGGTGTTCGACTTCTGCGAGCC-3’</p><p>CDK9-screen-F: 5’-CCCCGTAGCTGGTGCTTCCTCG-3’</p><p>CDK9-screen-R: 5’-CCCCAGCAGCCTTCATGTCCCTAT-3’</p></sec><sec id="s4-4"><title>Antibodies and western blot analysis</title><p>Proteins equivalent to 1 × 10<sup>5</sup> Raji B cells were loaded in Laemmli buffer and subjected to SDS-PAGE before transfer to nitrocellulose. Unspecific binding of antibodies was blocked by incubation of the membrane with 5% milk in Tris-buffered saline containing 1% Tween. Primary antibodies were anti-CDK9 (sc-484) (Santa Cruz, Dallas, TX USA) and anti-α-tubulin (DM1A) (Sigma-Aldrich, St. Louis, MO USA). Fluorophore-coupled secondary antibodies (Rockland Immunochemicals Inc., Pottstown, PA USA) were used and blots were visualized using the Odyssey system (LI-COR, Lincoln, NE USA).</p></sec><sec id="s4-5"><title>MTS assay</title><p>Cell proliferation at increasing 1-NA-PP1 inhibitor concentrations was measured in four biological replicates using the CellTiter 96 AQueous One Solution Cell Proliferation Assay System (Promega, Madison, WI USA). Cells were seeded in a 96-well plate and increasing concentrations of 1-NA-PP1 (Calbiochem, EMD Millipore, Danvers, MA USA) or DMSO (Sigma-Aldrich, St. Louis, MO USA) were added. After 72 hr, MTS tetrazolium compound was added to each well for one hour. Subsequently, the quantity of the MTS formazan product was measured as absorbance at 490 nm with a Sunrise photometer (TECAN, Männedorf, Switzerland) that was operated using the Magellan data analysis software (v7.2, TECAN, Männedorf, Switzerland). Relative signals for each concentration were calculated by dividing the signals of the CDK9<sup>as</sup> inhibitor treated cells by the corresponding signals of the control.</p></sec><sec id="s4-6"><title>TT-seq</title><p>Two biological replicates of reactions including RNA spike-ins were performed essentially as described (<xref ref-type="bibr" rid="bib50">Schwalb et al., 2016</xref>). Briefly, 3.3 × 10<sup>7</sup> Raji B (CDK9<sup>as</sup> or wild type) cells were treated for 15 min with solvent DMSO (control) or 5 µM of 1-NA-PP1 (CDK9<sup>as</sup> inhibitor). After 10 min of treatment, labeling was performed by adding 500 µM of 4-thiouracil (4sU) (Sigma-Aldrich, St. Louis, MO, USA) for 5 min at 37°C and 5% CO<sub>2</sub>. Cells were harvested by centrifugation at 3000 x g for 2 min. Total RNA was extracted using QIAzol according to the manufacturer’s instructions. RNAs were sonicated to generate fragments of &lt;1.5 kbp using AFAmicro tubes in a S220 Focused-ultrasonicator (Covaris Inc., Woburn, MA USA). 4sU-labeled RNA was purified from 150 µg total fragmented RNA. Separation of labeled RNA was achieved with streptavidin beads (Miltenyi Biotec, Bergisch Gladbach, Germany) as described in (<xref ref-type="bibr" rid="bib50">Schwalb et al., 2016</xref>). Prior to library preparation, 4sU-labeled RNA was purified and quantified. Enrichment of 4sU-labeled RNA was analyzed by RT-qPCR as described (<xref ref-type="bibr" rid="bib50">Schwalb et al., 2016</xref>). Input RNA was treated with HL-dsDNase (ArcticZymes, Tromsø, Norway) and used for strand-specific library preparation according to the Ovation Universal RNA-Seq System (NuGEN, Leek, The Netherlands). The size-selected and pre-amplified fragments were analyzed on a Fragment Analyzer before clustering and sequencing on the Illumina HiSeq 1500.</p></sec><sec id="s4-7"><title>TT-seq data preprocessing and global normalization</title><p>Paired-end 50 base reads with additional 6 base reads of barcodes were obtained for each of the samples, that is two TT-seq replicates with 1-NA-PP1 (CDK9<sup>as</sup> inhibitor) and two TT-Seq replicates with DMSO (control) treatment. Reads were demultiplexed and mapped with STAR 2.3.0 (<xref ref-type="bibr" rid="bib11">Dobin and Gingeras, 2015</xref>) to the hg20/hg38 (GRCh38) genome assembly (Human Genome Reference Consortium). Samtools (<xref ref-type="bibr" rid="bib27">Li et al., 2009</xref>) was used to quality filter SAM files, whereby alignments with MAPQ smaller than 7 (-q 7) were skipped and only proper pairs (-f2) were selected. Further data processing was carried out using the R/Bioconductor environment. We used a spike-in (RNAs) normalization strategy essentially as described (<xref ref-type="bibr" rid="bib50">Schwalb et al., 2016</xref>) to allow observation of global shifts and antisense bias determination (ratio of spurious reads originating from the opposite strand introduced by the RT reactions). Read counts for spike-ins were calculated using HTSeq (<xref ref-type="bibr" rid="bib2">Anders et al., 2015</xref>). Sequencing depth calculations did not detect global differences. Antisense bias ratios were calculated for each sample <italic>j</italic> according to<disp-formula id="equ1"><mml:math id="m1"><mml:msub><mml:mrow><mml:mi>c</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mrow><mml:mrow><mml:munder><mml:mrow><mml:mi mathvariant="normal">median</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:munder></mml:mrow><mml:mo>⁡</mml:mo><mml:mrow><mml:mfenced separators="|"><mml:mrow><mml:mfrac><mml:mrow><mml:msubsup><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>s</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:mi>s</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msubsup></mml:mrow><mml:mrow><mml:msubsup><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:mi>s</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msubsup></mml:mrow></mml:mfrac></mml:mrow></mml:mfenced></mml:mrow></mml:mrow></mml:math></disp-formula></p><p>for all available spike-ins <italic>i</italic>.</p></sec><sec id="s4-8"><title>Definition of transcription units (TUs)</title><p>For each annotated gene, transcription units (TUs) were defined as the union of all existing inherent transcript isoforms (UCSC RefSeq GRCh38). Read counts for all features were calculated using HTSeq (<xref ref-type="bibr" rid="bib2">Anders et al., 2015</xref>) and corrected for antisense bias using antisense bias ratios <inline-formula><mml:math id="inf12"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>c</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> calculated as described above. The real number of read counts <italic>s<sub>ij</sub></italic> for transcribed unit <italic>i</italic> in sample <italic>j</italic> was calculated as<disp-formula id="equ2"><mml:math id="m2"><mml:msub><mml:mrow><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mi>c</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>A</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msubsup><mml:mrow><mml:mi>c</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:mrow></mml:mfrac></mml:math></disp-formula></p><p>where <italic>S<sub>ij</sub></italic> and <italic>A<sub>ij</sub></italic> are the observed number of read counts on the sense and antisense strand. Read counts per kilobase (RPK) were calculated upon bias corrected read counts falling into the region of a transcribed unit divided by it’s length in kilobases. Based on the antisense bias corrected RPKs a subgroup of expressed TUs was defined to comprise all TUs with an RPK of 100 or higher in two summarized replicates of TT-seq without inhibitor treatment. An RPK of 100 corresponds to approximately a coverage of 10 per sample due to an average fragment size of 200. This subset was used throughout the analysis unless stated otherwise.</p></sec><sec id="s4-9"><title>Calculation of the number of transcribed bases</title><p>Aligned duplicated fragments were discarded for each sample. Of the resulting unique fragment isoforms only those were kept that exhibited a positive inner mate distance. The number of transcribed bases (<italic>tb<sub>j</sub></italic>) for all samples was calculated as the sum of the coverage of evident (sequenced) fragment parts (read pairs only) for all fragments smaller than 500 bases in length and with an inner mate interval not entirely overlapping a Refseq annotated intron (UCSC RefSeq GRCh38, ~96% of all fragments) in addition to the sum of the coverage of non-evident fragment parts (entire fragment).</p></sec><sec id="s4-10"><title>Size factor normalization</title><p>We first checked that no significant global shifts were detected in a comparison of two TT-seq replicates with 1-NA-PP1 (CDK9<sup>as</sup> inhibitor) treatment against two TT-seq replicates with DMSO treatment (control) in the above described spike-ins normalization strategy. Then all samples were subjected to an alternative, more robust normalization procedure. For each sample <italic>j</italic> the antisense bias corrected number of transcribed bases <italic>tb<sub>j</sub></italic> was calculated on all expressed TUs <italic>i</italic> exceeding 125 kbp in length. 50 kbp were truncated from each side of the selected TUs to avoid influence of the response to CDK9<sup>as</sup> inhibition (<xref ref-type="bibr" rid="bib26">Laitem et al., 2015</xref>). On the resulting intervals, size factors for each sample j were determined as<disp-formula id="equ3"><mml:math id="m3"><mml:msub><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mrow><mml:mrow><mml:munder><mml:mrow><mml:mi mathvariant="normal">median</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:munder></mml:mrow><mml:mo>⁡</mml:mo><mml:mrow><mml:mfenced separators="|"><mml:mrow><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>t</mml:mi><mml:mi>b</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mfenced separators="|"><mml:mrow><mml:mrow><mml:msubsup><mml:mo>∏</mml:mo><mml:mrow><mml:mi>v</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>m</mml:mi></mml:mrow></mml:msubsup><mml:mrow><mml:msub><mml:mrow><mml:mi>t</mml:mi><mml:mi>b</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>/</mml:mo><mml:mi>m</mml:mi></mml:mrow></mml:msup></mml:mrow></mml:mfrac></mml:mrow></mml:mfenced></mml:mrow></mml:mrow></mml:math></disp-formula></p><p>where <italic>m</italic> denotes the number of samples. This formula has been adapted (<xref ref-type="bibr" rid="bib1">Anders and Huber, 2010</xref>) and was used to correct for library size and sequencing depth variations.</p></sec><sec id="s4-11"><title>Calculation of response ratios</title><p>For each condition j (control or CDK9<sup>as</sup> inhibited) the antisense bias corrected number of transcribed bases <inline-formula><mml:math id="inf13"><mml:msubsup><mml:mrow><mml:mi>t</mml:mi><mml:mi>b</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msubsup></mml:math></inline-formula> was calculated on all expressed TUs <italic>i</italic> exceeding 10 kbp in length. Of all remaining TUs only those were kept harboring one unique TSS given all Refseq annotated isoforms (UCSC RefSeq GRCh38). Response ratios were calculated for a window from the TSS to 10 kbp downstream (excluding the first 200 bp) for each TU <italic>i</italic> as<disp-formula id="equ4"><mml:math id="m4"><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo> <mml:mi/><mml:msubsup><mml:mrow><mml:mi>t</mml:mi><mml:mi>b</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>i</mml:mi> <mml:mi/></mml:mrow><mml:mrow><mml:mo>[</mml:mo><mml:mn>0.2</mml:mn> <mml:mi mathvariant="normal"/><mml:mo>,</mml:mo> <mml:mi mathvariant="normal"/><mml:mn>10</mml:mn> <mml:mi mathvariant="normal"/><mml:mi mathvariant="normal">k</mml:mi><mml:mi mathvariant="normal">b</mml:mi><mml:mi mathvariant="normal">p</mml:mi><mml:mo>]</mml:mo></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>C</mml:mi><mml:mi>D</mml:mi><mml:mi>K</mml:mi><mml:mn>9</mml:mn></mml:mrow><mml:mrow><mml:mi>a</mml:mi><mml:mi>s</mml:mi></mml:mrow></mml:msup> <mml:mi mathvariant="normal"/><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>h</mml:mi><mml:mi>i</mml:mi><mml:mi>b</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi><mml:mi>e</mml:mi><mml:mi>d</mml:mi></mml:mrow></mml:msubsup><mml:mo>/</mml:mo><mml:msubsup><mml:mrow><mml:mi>t</mml:mi><mml:mi>b</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>i</mml:mi> <mml:mi/></mml:mrow><mml:mrow><mml:mo>[</mml:mo><mml:mn>0.2</mml:mn> <mml:mi mathvariant="normal"/><mml:mo>,</mml:mo> <mml:mi mathvariant="normal"/><mml:mn>10</mml:mn> <mml:mi mathvariant="normal"/><mml:mi mathvariant="normal">k</mml:mi><mml:mi mathvariant="normal">b</mml:mi><mml:mi mathvariant="normal">p</mml:mi><mml:mo>]</mml:mo></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>C</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mi>r</mml:mi><mml:mi>o</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msubsup></mml:math></disp-formula></p><p>where negative values were set to 0.</p></sec><sec id="s4-12"><title>Estimation of robust common elongation velocity</title><p>For each condition j (control or CDK9<sup>as</sup> inhibited) the antisense bias corrected number of transcribed bases <inline-formula><mml:math id="inf14"><mml:msubsup><mml:mrow><mml:mi>t</mml:mi><mml:mi>b</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msubsup></mml:math></inline-formula> was calculated on all expressed TUs <italic>i</italic> with a given response ratio <inline-formula><mml:math id="inf15"><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>, excluding the first 200 bp. All TUs were truncated by 5 kbp in length from the 3’ end prior to calculation to avoid influence of some alterations in signal around the pA site after CDK9<sup>as</sup> inhibition (<xref ref-type="bibr" rid="bib26">Laitem et al., 2015</xref>). A robust common elongation velocity estimate was calculated by finding an optimal fit for all TUs <italic>i</italic> between 25 to 200 kbp in length <italic>L<sub>i</sub></italic>, that is minimizing the function<disp-formula id="equ5"><mml:math id="m5"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi>l</mml:mi><mml:mi>o</mml:mi><mml:mi>s</mml:mi><mml:mi>s</mml:mi><mml:mo>=</mml:mo><mml:munder><mml:mrow><mml:mi mathvariant="normal">m</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">d</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">n</mml:mi></mml:mrow><mml:mi>i</mml:mi></mml:munder><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mo>|</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mfrac><mml:mrow><mml:mi>t</mml:mi><mml:msubsup><mml:mi>b</mml:mi><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mi>C</mml:mi><mml:mi>D</mml:mi><mml:mi>K</mml:mi><mml:msup><mml:mn>9</mml:mn><mml:mrow><mml:mi>a</mml:mi><mml:mi>s</mml:mi></mml:mrow></mml:msup><mml:mspace width="thinmathspace"/><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>h</mml:mi><mml:mi>i</mml:mi><mml:mi>b</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi><mml:mi>e</mml:mi><mml:mi>d</mml:mi></mml:mrow></mml:msubsup></mml:mrow><mml:mrow><mml:mi>t</mml:mi><mml:msubsup><mml:mi>b</mml:mi><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mi>C</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mi>r</mml:mi><mml:mi>o</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msubsup></mml:mrow></mml:mfrac><mml:mo>−</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>r</mml:mi><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msup><mml:mi>t</mml:mi><mml:mrow><mml:mo>∗</mml:mo></mml:mrow></mml:msup><mml:mo>−</mml:mo><mml:mi>t</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:msub><mml:mi>L</mml:mi><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mfrac></mml:mrow><mml:mo>|</mml:mo></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mstyle></mml:math></disp-formula></p><p>on the interval [0,10000] with inhibitor treatment duration <italic>t<sup>*</sup></italic>=15 [min] and labeling duration <italic>t</italic> = 5 [min], given that<disp-formula id="equ6"><mml:math id="m6"><mml:msubsup><mml:mrow><mml:mi>t</mml:mi><mml:mi>b</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>C</mml:mi><mml:mi>D</mml:mi><mml:mi>K</mml:mi><mml:mn>9</mml:mn></mml:mrow><mml:mrow><mml:mi>a</mml:mi><mml:mi>s</mml:mi></mml:mrow></mml:msup> <mml:mi mathvariant="normal"/><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>h</mml:mi><mml:mi>i</mml:mi><mml:mi>b</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi><mml:mi>e</mml:mi><mml:mi>d</mml:mi></mml:mrow></mml:msubsup><mml:mo>-</mml:mo><mml:msubsup><mml:mrow><mml:mi>t</mml:mi><mml:mi>b</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mi>C</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mi>r</mml:mi><mml:mi>o</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mfrac><mml:mrow><mml:msubsup><mml:mrow><mml:mi>t</mml:mi><mml:mi>b</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mi>C</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mi>r</mml:mi><mml:mi>o</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msubsup></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>L</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:msub><mml:mrow><mml:mi>v</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mfenced separators="|"><mml:mrow><mml:msup><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>*</mml:mi></mml:mrow></mml:msup><mml:mo>-</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:mfenced></mml:math></disp-formula></p><p>that is the difference of transcribed bases obtained by the CDK9<sup>as</sup> inhibitor treatment equals the number of transcribed bases per nucleotide <inline-formula><mml:math id="inf16"><mml:msubsup><mml:mrow><mml:mi>t</mml:mi><mml:mi>b</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mi>C</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mi>r</mml:mi><mml:mi>o</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msubsup><mml:mo>/</mml:mo><mml:msub><mml:mrow><mml:mi>L</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> times the number of nucleotides traveled <inline-formula><mml:math id="inf17"><mml:msub><mml:mrow><mml:mi>v</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mfenced separators="|"><mml:mrow><mml:msup><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>*</mml:mi></mml:mrow></mml:msup><mml:mo>-</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:mfenced></mml:math></inline-formula> in <inline-formula><mml:math id="inf18"><mml:msup><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>*</mml:mi></mml:mrow></mml:msup><mml:mo>-</mml:mo><mml:mi>t</mml:mi></mml:math></inline-formula> minutes corrected by the amount of the response <inline-formula><mml:math id="inf19"><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>.</p></sec><sec id="s4-13"><title>Estimation of gene-wise elongation velocity</title><p>For each condition <italic>j</italic> (control or CDK9<sup>as</sup> inhibited) the antisense bias corrected number of transcribed bases <inline-formula><mml:math id="inf20"><mml:msubsup><mml:mrow><mml:mi>t</mml:mi><mml:mi>b</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msubsup></mml:math></inline-formula> was calculated on all expressed TUs <italic>i</italic> exceeding 35 kbp in length, excluding the first 200 bp. All TUs were truncated by 5 kbp in length from the 3’ end prior to calculation to avoid influence of some alterations in signal around the pA site after CDK9<sup>as</sup> inhibition (<xref ref-type="bibr" rid="bib26">Laitem et al., 2015</xref>). Of all remaining TUs only those were kept harboring one unique TSS given all Refseq annotated isoforms (UCSC RefSeq GRCh38). For each TU <italic>i</italic> with <inline-formula><mml:math id="inf21"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>r</mml:mi><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>&gt;</mml:mo><mml:mn>0.25</mml:mn></mml:mrow></mml:mstyle></mml:math></inline-formula> the elongation velocity <italic>v<sub>i</sub></italic> [kbp/min] was calculated as<disp-formula id="equ7"><mml:math id="m7"><mml:msub><mml:mrow><mml:mi>v</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msubsup><mml:mrow><mml:mi>t</mml:mi><mml:mi>b</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mi>C</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mi>r</mml:mi><mml:mi>o</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msubsup><mml:mo>-</mml:mo><mml:msubsup><mml:mrow><mml:mi>t</mml:mi><mml:mi>b</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow> <mml:mi mathvariant="normal"/><mml:msup><mml:mrow><mml:mi>C</mml:mi><mml:mi>D</mml:mi><mml:mi>K</mml:mi><mml:mn>9</mml:mn></mml:mrow><mml:mrow><mml:mi>a</mml:mi><mml:mi>s</mml:mi></mml:mrow></mml:msup> <mml:mi mathvariant="normal"/><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>h</mml:mi><mml:mi>i</mml:mi><mml:mi>b</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi><mml:mi>e</mml:mi><mml:mi>d</mml:mi></mml:mrow></mml:msubsup></mml:mrow><mml:mrow><mml:msubsup><mml:mrow><mml:mi>t</mml:mi><mml:mi>b</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mi>C</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mi>r</mml:mi><mml:mi>o</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msubsup><mml:mo>∙</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>L</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mfenced separators="|"><mml:mrow><mml:msup><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>*</mml:mi></mml:mrow></mml:msup><mml:mo>-</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:mfenced></mml:mrow></mml:mfrac></mml:math></disp-formula></p><p>with inhibitor treatment duration <italic>t<sup>*</sup></italic>=15 [min] and labeling duration <italic>t</italic> = 5 [min].</p></sec><sec id="s4-14"><title>mNET-seq</title><p>Two biological replicates of reactions including empigen BB detergent treatment during immunoprecipitation (IP) were performed essentially as described (<xref ref-type="bibr" rid="bib38">Nojima et al., 2016</xref>; <xref ref-type="bibr" rid="bib49">Schlackow et al., 2017</xref>), with minor modifications. Briefly, 1.6 × 10<sup>8</sup> Raji B (CDK9<sup>as</sup>) cells were treated for 15 min with solvent DMSO (control) or 5 µM of 1-NA-PP1 (CDK9<sup>as</sup> inhibitor). Cell fractionation was performed as described (<xref ref-type="bibr" rid="bib7">Conrad and Ørom, 2017</xref>). Isolated chromatin was digested with micrococcal nuclease (MNase) (NEB, Ipswich, MA USA) at 37°C and 1,400 rpm for 90 s. To inactivate MNase, EGTA was added to a final concentration of 25 mM. Digested chromatin was collected by centrifugation at 4°C and 13,000 rpm for 5 min. The supernatant was diluted tenfold with IP buffer containing 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.05% (vol/vol) NP-40, and 1% (vol/vol) empigen BB (Sigma-Aldrich, St. Louis, MO USA). For each IP, 50 µg of Pol II antibody clone MABI0601 (BIOZOL, Eching, Germany) was conjugated to Dynabeads M-280 Sheep Anti-Mouse IgG (Thermo Fisher Scientific, Waltham, MA USA). Pol II antibody-conjugated beads were added to diluted sample. IP was performed on a rotating wheel at 4°C for 1 hr. The beads were washed six times with IP buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.05 % NP-40, and 1% empigen BB) and once with 500 µL of PNKT buffer containing 1 x T4 polynucleotide kinase (PNK) buffer (NEB, Ipswich, MA USA) and 0.1% (vol/vol) Tween-20 (Sigma-Aldrich, St. Louis, MO USA). Beads were incubated in 100 µL of PNK reaction mix containing 1 x PNK buffer, 0.1% (vol/vol) Tween-20, 1 mM ATP, and T4 PNK, 3’ phosphatase minus (NEB, Ipswich, MA USA) at 37°C for 10 min. Beads were washed once with IP buffer. RNA was extracted with TRIzol reagent. RNA was precipitated with GlycoBlue co-precipitant (Thermo Fisher Scientific, Waltham, MA USA) and resolved on 6% denaturing acrylamide containing 7 M urea (PanReac AppliChem, Darmstadt, Germany) gel for size purification. Fragments of 35–100 nt were eluted from the gel using elution buffer containing 1 M NaOAc, 1 mM EDTA, and precipitated in ethanol. RNA libraries were prepared according to the TruSeq Small RNA Library Kit (Illumina, Massachusetts USA) and as described (<xref ref-type="bibr" rid="bib38">Nojima et al., 2016</xref>). The size-selected and pre-amplified fragments were analyzed on a Fragment Analyzer before clustering and sequencing on an Illumina HiSeq 2500 sequencer.</p></sec><sec id="s4-15"><title>mNET-seq data preprocessing and normalization</title><p>Paired-end 50 base reads with additional 6 base reads of barcodes were obtained for each of the samples, that is mNET-seq samples with 1-NA-PP1 (CDK9<sup>as</sup> inhibitor) and with DMSO (control) treatment. Reads were demultiplexed and mapped with STAR 2.3.0 (<xref ref-type="bibr" rid="bib11">Dobin and Gingeras, 2015</xref>) to the hg20/hg38 (GRCh38) genome assembly (Human Genome Reference Consortium). Samtools (<xref ref-type="bibr" rid="bib27">Li et al., 2009</xref>) was used to quality filter SAM files, whereby alignments with MAPQ smaller than 7 (-q 7) were skipped and only proper pairs (-f2) were selected. Further data processing was carried out using the R/Bioconductor environment. Antisense bias (ratio of spurious reads originating from the opposite strand introduced by the RT reactions) was determined using positions in regions without antisense annotation with a coverage of at least 100 according to Refseq annotated genes (UCSC RefSeq GRCh38). mNET-seq coverage tracks were size factor normalized on 260 TUs that showed a response of less than 5% (<inline-formula><mml:math id="inf22"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>r</mml:mi><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>&lt;</mml:mo><mml:mn>0.05</mml:mn></mml:mrow></mml:mstyle></mml:math></inline-formula>) in the TT-seq signal upon 1-NA-PP1 (CDK9<sup>as</sup> inhibitor) treatment. The response ratio <inline-formula><mml:math id="inf23"><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> was determined as described above including also TUs with multiple TSS to extend the number of TUs for normalization. Note that variation of the response ratio cutoff and thereby the number of TUs available for normalization does virtually not change the normalization parameters. Coverage tracks for further analysis were restricted to the last nucleotide incorporated by the polymerase in the aligned mNET-seq reads.</p></sec><sec id="s4-16"><title>Detection of pause sites</title><p>For all expressed TUs <italic>i</italic> exceeding 10 kbp in length with one unique TSS given all Refseq annotated isoforms (UCSC RefSeq GRCh38) the pause site <italic>m*</italic> was calculated for all bases <italic>m</italic> in a window from the TSS to the end of the first exon (excluding the last 5 bases) via maximizing the function<disp-formula id="equ8"><mml:math id="m8"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>ρ</mml:mi><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:munder><mml:mo form="prefix">max</mml:mo><mml:mi>m</mml:mi></mml:munder><mml:mspace width="thinmathspace"/><mml:msub><mml:mi>p</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>m</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></disp-formula></p><p>where <inline-formula><mml:math id="inf24"><mml:msub><mml:mrow><mml:mi>ρ</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> needed to exceed 5 times the median of the signal strength <inline-formula><mml:math id="inf25"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>m</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> for all non-negative antisense bias corrected mNET-seq coverage values (<xref ref-type="bibr" rid="bib39">Nojima et al., 2015</xref>). Note that all provided coverage tracks were used.</p></sec><sec id="s4-17"><title>DNA-RNA and DNA-DNA melting temperature calculation</title><p>The gene-wise mean melting temperature of the DNA-RNA and DNA-DNA hybrid was calculated from subsequent melting temperature estimates of 8-base pair DNA-RNA and DNA-DNA duplexes tiling the respective area according to (<xref ref-type="bibr" rid="bib47">SantaLucia, 1998</xref>; <xref ref-type="bibr" rid="bib54">Sugimoto et al., 1995</xref>).</p></sec><sec id="s4-18"><title>Molecular weight conversions</title><p>The known sequence and mixture of the utilized spike-ins allows to calculate a conversion factor to RNA amount per cell [cell<sup>−1</sup>] given their molecular weight assuming perfect RNA extraction. The number of spike-in molecules per cell <italic>N</italic> [cell<sup>−1</sup>] was calculated as<disp-formula id="equ9"><mml:math id="m9"><mml:mi>N</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>m</mml:mi></mml:mrow><mml:mrow><mml:mi>M</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:mfrac><mml:msub><mml:mrow><mml:mi>N</mml:mi></mml:mrow><mml:mrow><mml:mi>A</mml:mi></mml:mrow></mml:msub></mml:math></disp-formula></p><p>with the number of spike-ins <italic>m</italic> 25.10<sup>−9</sup> [g], the number of cells <italic>n</italic> 3.27.10<sup>7</sup>, the Avogadro constant <italic>N<sub>A</sub></italic> 6.02214085774.10<sup>23</sup> [mol<sup>−1</sup>] and molar-mass (molecular weight) of the spike-ins <italic>M</italic> [g mol<sup>−1</sup>] calculated as<disp-formula id="equ10"><mml:math id="m10"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi>M</mml:mi><mml:mrow><mml:mtext> </mml:mtext></mml:mrow><mml:mo>=</mml:mo><mml:mrow><mml:mtext> </mml:mtext></mml:mrow><mml:msub><mml:mi>A</mml:mi><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:mo>⋅</mml:mo><mml:mn>329.2</mml:mn><mml:mrow><mml:mtext> </mml:mtext></mml:mrow><mml:mo>+</mml:mo><mml:mrow><mml:mtext> </mml:mtext></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mi>τ</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>⋅</mml:mo><mml:msub><mml:mi>U</mml:mi><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:mo>⋅</mml:mo><mml:mn>306.2</mml:mn><mml:mrow><mml:mtext> </mml:mtext></mml:mrow><mml:mo>+</mml:mo><mml:mrow><mml:mtext> </mml:mtext></mml:mrow><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:mo>⋅</mml:mo><mml:mn>305.2</mml:mn><mml:mrow><mml:mtext> </mml:mtext></mml:mrow><mml:mo>+</mml:mo><mml:mrow><mml:mtext> </mml:mtext></mml:mrow><mml:msub><mml:mi>G</mml:mi><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:mo>⋅</mml:mo><mml:mn>345.2</mml:mn><mml:mspace linebreak="newline"/><mml:mrow><mml:mtext> </mml:mtext></mml:mrow><mml:mo>+</mml:mo><mml:mrow><mml:mtext> </mml:mtext></mml:mrow><mml:mrow><mml:mi>τ</mml:mi></mml:mrow><mml:mo>⋅</mml:mo><mml:mn>4</mml:mn><mml:mi>s</mml:mi><mml:msub><mml:mi>U</mml:mi><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:mo>⋅</mml:mo><mml:mn>322.26</mml:mn><mml:mrow><mml:mtext> </mml:mtext></mml:mrow><mml:mo>+</mml:mo><mml:mrow><mml:mtext> </mml:mtext></mml:mrow><mml:mn>159</mml:mn></mml:mrow></mml:mstyle></mml:math></disp-formula></p><p>where A<sub>n</sub>, U<sub>n</sub>, C<sub>n</sub>, G<sub>n</sub> and 4sU<sub>n</sub> are the number of each respective nucleotide within each spike-in polynucleotide. <inline-formula><mml:math id="inf26"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi>τ</mml:mi></mml:mrow></mml:mstyle></mml:math></inline-formula> is set to 0.1 in case of a labeled spike-in and 0 otherwise. The addition of 159 to the molecular weight takes into account the molecular weight of a 5' triphosphate. Provided the above the conversion factor to RNA amount per cell <inline-formula><mml:math id="inf27"><mml:mi>κ</mml:mi></mml:math></inline-formula> [cell<sup>−1</sup>] can be calculated as<disp-formula id="equ11"><mml:math id="m11"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi>κ</mml:mi><mml:mo>=</mml:mo><mml:munder><mml:mrow><mml:mi mathvariant="normal">m</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">n</mml:mi></mml:mrow><mml:mtext> </mml:mtext></mml:munder><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:munder><mml:mrow><mml:mi mathvariant="normal">m</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">d</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">n</mml:mi></mml:mrow><mml:mi>i</mml:mi></mml:munder><mml:mrow><mml:mo>(</mml:mo><mml:mfrac><mml:mrow><mml:mi>t</mml:mi><mml:msub><mml:mi>b</mml:mi><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>L</mml:mi><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>⋅</mml:mo><mml:mi>N</mml:mi></mml:mrow></mml:mfrac><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mstyle></mml:math></disp-formula></p><p>for all labeled spike-in species <italic>i</italic> with length <italic>L<sub>i</sub></italic>. Note that imperfect RNA extraction efficiency would lead to an underestimation of cellular labeled RNA in comparison to the amount of added spike-ins and thus to an underestimation of initiation frequencies. In case of a strong underestimation however the real initiation frequencies would lie above the pause-initiation limit, which is theoretically impossible. Thus we assume this effect to be insignificant.</p></sec><sec id="s4-19"><title>Estimation of initiation frequency <italic>I</italic></title><p>The antisense bias corrected number of transcribed bases <inline-formula><mml:math id="inf28"><mml:msubsup><mml:mrow><mml:mi>t</mml:mi><mml:mi>b</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mi>C</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mi>r</mml:mi><mml:mi>o</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msubsup></mml:math></inline-formula> was calculated on all expressed TUs <italic>i</italic> exceeding 10 kbp in length. Of all remaining TUs only those were kept harboring one unique TSS given all Refseq annotated isoforms (UCSC RefSeq GRCh38). For each TU <italic>i</italic> the productive initiation frequency <italic>I<sub>i</sub></italic> [cell<sup>−1</sup>min<sup>−1</sup>], which corresponds to the pause release rate, was calculated as<disp-formula id="equ12"><mml:math id="m12"><mml:msub><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>κ</mml:mi></mml:mrow></mml:mfrac><mml:mo>∙</mml:mo><mml:mfrac><mml:mrow><mml:msubsup><mml:mrow><mml:mi>t</mml:mi><mml:mi>b</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mi>C</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mi>r</mml:mi><mml:mi>o</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msubsup></mml:mrow><mml:mrow><mml:mi>t</mml:mi><mml:mo>∙</mml:mo><mml:msub><mml:mrow><mml:mi>L</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:math></disp-formula></p><p>with labeling duration <italic>t</italic> = 5 [min] and length <italic>L<sub>i</sub></italic>. Note that <inline-formula><mml:math id="inf29"><mml:msubsup><mml:mrow><mml:mi>t</mml:mi><mml:mi>b</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mi>C</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mi>r</mml:mi><mml:mi>o</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msubsup></mml:math></inline-formula> and <italic>L<sub>i</sub></italic> were restricted to regions of non-first constitutive exons (exonic bases common to all isoforms).</p></sec><sec id="s4-20"><title>Estimation of pause duration <italic>d</italic></title><p>For all expressed TUs <italic>i</italic> exceeding 10 kbp in length with one unique TSS given all Refseq annotated isoforms (UCSC RefSeq GRCh38) the pause duration <italic>d<sub>i</sub></italic> [min] was calculated as the residing time of the polymerase in a window ±100 bases <italic>m</italic> around the pause site (see above) as<disp-formula id="equ13"><mml:math id="m13"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mo movablelimits="false">∑</mml:mo><mml:mrow><mml:mo>+</mml:mo><mml:mrow><mml:mo>/</mml:mo></mml:mrow><mml:mo>−</mml:mo><mml:mn>100</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:msub><mml:mi>p</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>m</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mfrac><mml:mo>.</mml:mo><mml:munder><mml:mrow><mml:mi mathvariant="normal">m</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">d</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">n</mml:mi></mml:mrow><mml:mi>i</mml:mi></mml:munder><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mfrac><mml:msub><mml:mi>v</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:msub><mml:mi>v</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:msup><mml:mi>t</mml:mi><mml:mo>∗</mml:mo></mml:msup><mml:mo>−</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mrow><mml:mo>/</mml:mo></mml:mrow><mml:msub><mml:mo movablelimits="false">∑</mml:mo><mml:mrow><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>s</mml:mi><mml:mi>p</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mi>s</mml:mi><mml:mi>e</mml:mi><mml:mtext> </mml:mtext><mml:mi>w</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>d</mml:mi><mml:mi>o</mml:mi><mml:mi>w</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:msub><mml:mi>p</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>m</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:mfrac></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mstyle></mml:math></disp-formula></p><p>with pause release rate <inline-formula><mml:math id="inf30"><mml:msub><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> and the number of polymerases <inline-formula><mml:math id="inf31"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>m</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> (antisense bias corrected mNET-seq coverage values [<xref ref-type="bibr" rid="bib39">Nojima et al., 2015</xref>]) in a window ±100 bases around the pause site. For pause sites below 100 bp downstream of the TSS the first 200 bp of the TU were considered. Note that the right part of the formula is restricted to mNETseq instances above the 50% quantile for robustness and adjusts <italic>d<sub>i</sub></italic> to an absolute scale by comparing the CDK9 derived elongation velocities<inline-formula><mml:math id="inf32"> <mml:mi/><mml:msub><mml:mrow><mml:mi>v</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> with those derived from combining mNET-seq and TT-seq data in the response window <inline-formula><mml:math id="inf33"><mml:mfenced close="]" open="[" separators="|"><mml:mrow><mml:mn>200</mml:mn><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi>v</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mfenced separators="|"><mml:mrow><mml:msup><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>*</mml:mi></mml:mrow></mml:msup><mml:mo>-</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:mfenced></mml:mrow></mml:mfenced></mml:math></inline-formula>.</p></sec><sec id="s4-21"><title>Pause-initiation limit</title><p>The previously derived inequality from (<xref ref-type="bibr" rid="bib13">Ehrensberger et al., 2013</xref>)<disp-formula id="equ14"><mml:math id="m14"><mml:mfrac><mml:mrow><mml:mi>v</mml:mi></mml:mrow><mml:mrow><mml:mi>I</mml:mi></mml:mrow></mml:mfrac><mml:mo>≥</mml:mo><mml:mn>50</mml:mn> <mml:mi/><mml:mo>[</mml:mo><mml:mi>b</mml:mi><mml:mi>p</mml:mi><mml:mo>]</mml:mo></mml:math></disp-formula></p><p>states that new initiation events into productive elongation are limited by the velocity of the polymerase in the promoter-proximal region and that steric hindrance occurs below a distance of 50 bp between the active sites of the initiating Pol II and the paused Pol II. Given the calculations of pause duration <inline-formula><mml:math id="inf34"><mml:mi>d</mml:mi></mml:math></inline-formula> and (productive) initiation frequency <inline-formula><mml:math id="inf35"><mml:mi>I</mml:mi></mml:math></inline-formula> above, we can reformulate this inequality to<disp-formula id="equ15"><mml:math id="m15"><mml:mfrac><mml:mrow><mml:mn>200</mml:mn> <mml:mi/><mml:mo>[</mml:mo><mml:mi>b</mml:mi><mml:mi>p</mml:mi><mml:mo>]</mml:mo></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mo>∙</mml:mo><mml:mi>I</mml:mi></mml:mrow></mml:mfrac><mml:mo>≥</mml:mo><mml:mn>50</mml:mn> <mml:mi/><mml:mo>[</mml:mo><mml:mi>b</mml:mi><mml:mi>p</mml:mi><mml:mo>]</mml:mo></mml:math></disp-formula></p><p>with 200 [bp] being the above defined pause window.</p></sec><sec id="s4-22"><title>Simulation of TT-seq data based on elongation velocity profiles</title><p>Based on the following model we simulated TT-seq coverage values by providing elongation velocity profiles <inline-formula><mml:math id="inf36"><mml:mi>v</mml:mi><mml:mfenced separators="|"><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:mfenced></mml:math></inline-formula>, a labeling duration <inline-formula><mml:math id="inf37"><mml:msup><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>l</mml:mi><mml:mi>a</mml:mi><mml:mi>b</mml:mi></mml:mrow></mml:msup></mml:math></inline-formula> and a uracil content dependent labeling bias<disp-formula id="equ16"><mml:math id="m16"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>l</mml:mi><mml:mrow><mml:mi>f</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msup><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msup><mml:mi>p</mml:mi><mml:mrow><mml:mi>l</mml:mi><mml:mi>a</mml:mi><mml:mi>b</mml:mi></mml:mrow></mml:msup></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mi mathvariant="normal">#</mml:mi><mml:msub><mml:mi>u</mml:mi><mml:mrow><mml:mi>f</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msup></mml:mrow></mml:mstyle></mml:math></disp-formula></p><p><inline-formula><mml:math id="inf38"><mml:msup><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>l</mml:mi><mml:mi>a</mml:mi><mml:mi>b</mml:mi></mml:mrow></mml:msup></mml:math></inline-formula> denotes the labeling probability (set to 0.05) and <inline-formula><mml:math id="inf39"><mml:mo>#</mml:mo><mml:msub><mml:mrow><mml:mi>u</mml:mi></mml:mrow><mml:mrow><mml:mi>f</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> the number of uracil residues of a given fragment <inline-formula><mml:math id="inf40"><mml:mi>f</mml:mi></mml:math></inline-formula> (set to 0.28 times fragment length). The elongation velocity profile <inline-formula><mml:math id="inf41"><mml:mi>v</mml:mi><mml:mfenced separators="|"><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:mfenced></mml:math></inline-formula> can be used to calculate the number of elongated positions of the polymerase <inline-formula><mml:math id="inf42"><mml:mi>τ</mml:mi><mml:mfenced separators="|"><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:mfenced></mml:math></inline-formula> at timepoint <inline-formula><mml:math id="inf43"><mml:mi>t</mml:mi></mml:math></inline-formula> as<disp-formula id="equ17"><mml:math id="m17"><mml:mi>τ</mml:mi><mml:mfenced separators="|"><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mrow><mml:msubsup><mml:mo>∫</mml:mo><mml:mrow><mml:mn>0</mml:mn></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msubsup><mml:mrow><mml:mi>v</mml:mi><mml:mfenced separators="|"><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:mfenced><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mrow></mml:math></disp-formula></p><p>Given the transcription start site <inline-formula><mml:math id="inf44"><mml:mi>τ</mml:mi><mml:mfenced separators="|"><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:mfenced></mml:math></inline-formula> the number of elongated positions <inline-formula><mml:math id="inf45"><mml:mi>τ</mml:mi><mml:mfenced separators="|"><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:mfenced></mml:math></inline-formula> can be used to determine the end of an emerging nascent fragment <inline-formula><mml:math id="inf46"><mml:mi>f</mml:mi></mml:math></inline-formula>. Based on that we determined the start position of a fragment as <inline-formula><mml:math id="inf47"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi>τ</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mo form="prefix" movablelimits="true">max</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>t</mml:mi><mml:mo>−</mml:mo><mml:msup><mml:mi>t</mml:mi><mml:mrow><mml:mi>l</mml:mi><mml:mi>a</mml:mi><mml:mi>b</mml:mi></mml:mrow></mml:msup><mml:mo>,</mml:mo><mml:mn>0</mml:mn></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mstyle></mml:math></inline-formula> for each labeling duration <inline-formula><mml:math id="inf48"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msup><mml:mi>t</mml:mi><mml:mrow><mml:mi>l</mml:mi><mml:mi>a</mml:mi><mml:mi>b</mml:mi></mml:mrow></mml:msup></mml:mrow></mml:mstyle></mml:math></inline-formula> as the position of the polymerase at the beginning of the labeling process. Subsequently, we used the number of uracil residues present in the RNA fragment <inline-formula><mml:math id="inf49"><mml:mo>#</mml:mo><mml:msub><mml:mrow><mml:mi>u</mml:mi></mml:mrow><mml:mrow><mml:mi>f</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> to weight the amount of coverage contributed by this fragment as <inline-formula><mml:math id="inf50"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>l</mml:mi><mml:mrow><mml:mi>f</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula>. Additionally, we applied a size selection similar to that in the original protocol for fragments below 80 bp in length with a sigmoidal curve that mimics a typical size selection spread. Given a pause position of 80 bp downstream of the TSS and pause duration of 1 or 2 min we adjusted the elongation velocity profile to simulate polymerase pausing. Note that neither reasonable changes in labeling probability, size selection probability nor changes in uracil residue content change the general observation that longer pause durations induce a greater shortage of TT-seq coverage in the region between the TSS and the pause site.</p></sec><sec id="s4-23"><title>Estimation of gene-wise elongation velocity (without of response ratio)</title><p>For each condition <italic>j</italic> (control or CDK9<sup>as</sup> inhibited) the antisense bias corrected number of transcribed bases <inline-formula><mml:math id="inf51"><mml:msubsup><mml:mrow><mml:mi>t</mml:mi><mml:mi>b</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msubsup></mml:math></inline-formula> was calculated on all expressed TUs <italic>i</italic> exceeding 35 kbp in length, excluding the first 200 bp. All TUs were truncated by 5 kb in length from the 3’ end prior to calculation to avoid influence of some alterations in signal around the pA site after CDK9<sup>as</sup> inhibition (<xref ref-type="bibr" rid="bib26">Laitem et al., 2015</xref>). Of all remaining TUs only those were kept harboring one unique TSS given all Refseq annotated isoforms (UCSC RefSeq GRCh38). For each TU <italic>i</italic> with <inline-formula><mml:math id="inf52"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>r</mml:mi><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>&gt;</mml:mo><mml:mn>0.25</mml:mn></mml:mrow></mml:mstyle></mml:math></inline-formula> the cumulative sums of the difference of the number of transcribed bases <inline-formula><mml:math id="inf53"><mml:msubsup><mml:mrow><mml:mi>t</mml:mi><mml:mi>b</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msubsup></mml:math></inline-formula> for each base k was calculated as<disp-formula id="equ18"><mml:math id="m18"><mml:msub><mml:mrow><mml:msub><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>0</mml:mn> <mml:mi/> <mml:mi/> <mml:mi/> <mml:mi/> <mml:mi/><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msubsup><mml:mrow><mml:mi>t</mml:mi><mml:mi>b</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mi>C</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mi>r</mml:mi><mml:mi>o</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msubsup><mml:mo>-</mml:mo><mml:msubsup><mml:mrow><mml:mi>t</mml:mi><mml:mi>b</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>C</mml:mi><mml:mi>D</mml:mi><mml:mi>K</mml:mi><mml:mn>9</mml:mn></mml:mrow><mml:mrow><mml:mi>a</mml:mi><mml:mi>s</mml:mi></mml:mrow></mml:msup> <mml:mi mathvariant="normal"/><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>h</mml:mi><mml:mi>i</mml:mi><mml:mi>b</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi><mml:mi>e</mml:mi><mml:mi>d</mml:mi></mml:mrow></mml:msubsup></mml:math></disp-formula></p><p>starting at the unique TSS (position 0) to <inline-formula><mml:math id="inf54"><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>L</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> the length of the TU. A elongation length estimate <inline-formula><mml:math id="inf55"><mml:msubsup><mml:mrow><mml:mi>L</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>s</mml:mi><mml:mi>p</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mi>s</mml:mi><mml:mi>e</mml:mi> <mml:mi/><mml:mi>w</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>d</mml:mi><mml:mi>o</mml:mi><mml:mi>w</mml:mi></mml:mrow></mml:msubsup></mml:math></inline-formula> was then calculated by finding an optimal fit for n between 0 to <inline-formula><mml:math id="inf56"><mml:msub><mml:mrow><mml:mi>L</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>, that is maximizing the function<disp-formula id="equ19"><mml:math id="m19"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi>g</mml:mi><mml:mi>a</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mrow><mml:mrow><mml:mover><mml:mstyle displaystyle="false" scriptlevel="1"><mml:mi>n</mml:mi></mml:mstyle><mml:mrow><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mo form="prefix" movablelimits="true">max</mml:mo></mml:mstyle></mml:mrow></mml:mover></mml:mrow></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mfrac><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:mo>⋅</mml:mo><mml:msub><mml:mi>L</mml:mi><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:munder><mml:mo form="prefix">max</mml:mo><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>1..</mml:mn><mml:msub><mml:mi>L</mml:mi><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:munder><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>−</mml:mo><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mstyle></mml:math></disp-formula></p><p>on the interval [0, <inline-formula><mml:math id="inf57"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>L</mml:mi><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula>]. In words, finding the maximum of the cumulative sums of difference in coverage rotated 45 degrees clockwise. The elongation velocity <inline-formula><mml:math id="inf58"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mrow><mml:mover><mml:mi>v</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> [kbp/min] was subsequently calculated as<disp-formula id="equ20"><mml:math id="m20"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mrow><mml:mover><mml:mi>v</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:msubsup><mml:mi>L</mml:mi><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>s</mml:mi><mml:mi>p</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mi>s</mml:mi><mml:mi>e</mml:mi><mml:mtext> </mml:mtext><mml:mi>w</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>d</mml:mi><mml:mi>o</mml:mi><mml:mi>w</mml:mi></mml:mrow></mml:msubsup><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msup><mml:mi>t</mml:mi><mml:mrow><mml:mo>∗</mml:mo></mml:mrow></mml:msup><mml:mo>−</mml:mo><mml:mi>t</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mfrac></mml:mrow></mml:mstyle></mml:math></disp-formula></p><p>with inhibitor treatment duration <italic>t<sup>*</sup></italic>=15 [min] and labeling duration <italic>t</italic> = 5 [min].</p></sec><sec id="s4-24"><title>Estimation of pause duration <inline-formula><mml:math id="inf59"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mrow><mml:mover><mml:mi mathvariant="bold-italic">d</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover></mml:mrow></mml:mrow></mml:mstyle></mml:math></inline-formula> (without of initiation frequency).</title><p>For all expressed TUs <italic>i</italic> exceeding 10 kb in length with one unique TSS given all Refseq annotated isoforms (UCSC RefSeq GRCh38) the pause duration <inline-formula><mml:math id="inf60"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mrow><mml:mover><mml:mi>d</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> [min] was calculated as the residing time of the polymerase in a window ±100 bases <italic>m</italic> around the pause site (see above) as<disp-formula id="equ21"><mml:math id="m21"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mrow><mml:mover><mml:msub><mml:mi>d</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">^</mml:mo></mml:mover></mml:mrow><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mo movablelimits="false">∑</mml:mo><mml:mrow><mml:mo>+</mml:mo><mml:mrow><mml:mo>/</mml:mo></mml:mrow><mml:mo>−</mml:mo><mml:mn>100</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:msub><mml:mi>p</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>m</mml:mi></mml:mrow></mml:msub><mml:mo>.</mml:mo><mml:msubsup><mml:mi>L</mml:mi><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>s</mml:mi><mml:mi>p</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mi>s</mml:mi><mml:mi>e</mml:mi><mml:mtext> </mml:mtext><mml:mi>w</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>d</mml:mi><mml:mi>o</mml:mi><mml:mi>w</mml:mi></mml:mrow></mml:msubsup></mml:mrow></mml:mrow><mml:mrow><mml:msub><mml:mo movablelimits="false">∑</mml:mo><mml:mrow><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>s</mml:mi><mml:mi>p</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mi>s</mml:mi><mml:mi>e</mml:mi><mml:mtext> </mml:mtext><mml:mi>w</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>d</mml:mi><mml:mi>o</mml:mi><mml:mi>w</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:msub><mml:mi>p</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>m</mml:mi></mml:mrow></mml:msub><mml:mo>.</mml:mo><mml:msub><mml:mrow><mml:mover><mml:mi>v</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover></mml:mrow><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:mfrac></mml:mrow></mml:mstyle></mml:math></disp-formula></p><p>with elongation length estimate <inline-formula><mml:math id="inf61"><mml:msubsup><mml:mrow><mml:mi>L</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>s</mml:mi><mml:mi>p</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mi>s</mml:mi><mml:mi>e</mml:mi> <mml:mi/><mml:mi>w</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>d</mml:mi><mml:mi>o</mml:mi><mml:mi>w</mml:mi></mml:mrow></mml:msubsup></mml:math></inline-formula> and the number of polymerases <inline-formula><mml:math id="inf62"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>m</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> (antisense bias corrected mNET-seq coverage values) in a window ±100 bases around the pause site. For pause sites below 100 bp downstream of the TSS the first 200 bp of the TU were considered. Note that <inline-formula><mml:math id="inf63"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mrow><mml:mover><mml:mi>d</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> was adjusted to the height as <inline-formula><mml:math id="inf64"><mml:msub><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> by a single proportionality factor for visualization purposes.</p></sec><sec id="s4-25"><title>In vivo RNA secondary structure (DMS-seq [<xref ref-type="bibr" rid="bib46">Rouskin et al., 2014</xref>])</title><p>The gene-wise DMS-seq coverage (300 μl in vivo) for a window of [−15,–65] bp upstream of the pause site was normalized by subtraction from the respective DMS-seq coverage (denatured) allowing for maximal 5% negative values which were set to 0 (sequencing depth adjustment). The gene-wise mean values were subsequently normalized by dividing with the initiation frequency. Note that the latter normalization has an insignificant effect.</p></sec><sec id="s4-26"><title>Prediction of RNA secondary structure</title><p>The gene-wise mean minimum free energy for a window of [−15,–65] bp upstream of the pause site was calculated from subsequent minimum free energy estimates of 13-base pair RNA fragments tiling the respective area using RNAfold from the ViennaRNA package (<xref ref-type="bibr" rid="bib30">Lorenz et al., 2011</xref>).</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We would like to thank Helmut Blum and Stefan Krebs (LAFUGA, LMU Munich) for sequencing. We also thank Merle Hantsche for structural modeling. We thank Julien Gagneur (Technical University of Munich) for initial discussions. HL was funded by SFB 1064 TP A17. DE was funded by SFB1064 (Chromatin Dynamics). PC was funded by Advanced Grant TRANSREGULON of the European Research Council and the Volkswagen Foundation.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Data curation, Validation, Investigation, Visualization, Methodology, Writing—original draft, Writing—review and editing, Optimized and carried out TT-seq and mNET-seq experiments and contributed to the design of bioinformatics analysis, Prepared the manuscript, with input from all authors</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Data curation, Software, Formal analysis, Supervision, Validation, Investigation, Visualization, Methodology, Writing—original draft, Writing—review and editing, Designed and carried out bioinformatics analysis, Designed and supervised research, Prepared the manuscript, with input from all authors</p></fn><fn fn-type="con" id="con3"><p>Validation, Visualization, Methodology, Carried out cellular and biochemical characterization of the CDK9as strain and contributed to TT-seq experiments of CDK9as strain</p></fn><fn fn-type="con" id="con4"><p>Validation, Visualization, Methodology, Generated and validated the CDK9as cell line</p></fn><fn fn-type="con" id="con5"><p>Resources, Supervision, Funding acquisition, Validation, Methodology, Designed and supervised CDK9as strain generation, validation and characterization</p></fn><fn fn-type="con" id="con6"><p>Conceptualization, Resources, Supervision, Funding acquisition, Validation, Methodology, DE designed and supervised CDK9as strain generation, validation and characterization</p></fn><fn fn-type="con" id="con7"><p>Conceptualization, Resources, Supervision, Funding acquisition, Investigation, Visualization, Methodology, Writing—original draft, Project administration, Writing—review and editing, Designed and supervised research, Prepared the manuscript, with input from all authors</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="supp1"><object-id pub-id-type="doi">10.7554/eLife.29736.018</object-id><label>Supplementary file 1.</label><caption><title>Published datasets used for analysis.</title><p>Note that the conclusions we draw across different cell-lines are all based on metagene analysis, involving from 500 up to more than 2000 genes. Thus, we assume cell-line specific differences to have an insignificant influence and that the tendencies we observe rather suggest strong conservation.</p></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-29736-supp1-v2.docx"/></supplementary-material><supplementary-material id="transrepform"><object-id pub-id-type="doi">10.7554/eLife.29736.019</object-id><label>Transparent reporting form</label><media mime-subtype="pdf" mimetype="application" xlink:href="elife-29736-transrepform-v2.pdf"/></supplementary-material><sec id="s7" sec-type="datasets"><title>Major datasets</title><p>The following dataset was generated:</p><p><related-object content-type="generated-dataset" id="dataset1" source-id="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE96056" source-id-type="uri"><collab collab-type="author">Gressel S</collab><collab collab-type="author">Schwalb B</collab><collab collab-type="author">Decker TM</collab><collab collab-type="author">Qin W</collab><collab collab-type="author">Leonhardt H</collab><collab collab-type="author">Eick D</collab><collab collab-type="author">Cramer P</collab><year>2017</year><source>CDK9-dependent RNA polymerase II pausing controls transcription initiation</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE96056">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE96056</ext-link><comment>Publicly available at the NCBI Gene Expression Omnibus (accession no: GSE96056)</comment></related-object></p><p>The following previously published datasets were used:</p><p><related-object content-type="generated-dataset" id="dataset2" source-id="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE35239" source-id-type="uri"><collab collab-type="author">Furey T</collab><collab collab-type="author">Boyle A</collab><collab collab-type="author">Song L</collab><collab collab-type="author">Crawford G</collab><collab collab-type="author">Giresi P</collab><collab collab-type="author">Lieb J</collab><collab collab-type="author">Liu Z</collab><collab collab-type="author">McDaniell R</collab><collab collab-type="author">Lee B</collab><collab collab-type="author">Iyer V</collab><collab collab-type="author">Flicek P</collab><collab collab-type="author">Keefe D</collab><collab collab-type="author">Birney E</collab><collab collab-type="author">Graf S</collab><year>2012</year><source>Open Chromatin by FAIRE from ENCODE/OpenChrom(UNC Chapel Hill)</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE35239">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE35239</ext-link><comment>Publicly available at the NCBI Gene Expression Omnibus (accession no: GSE35239)</comment></related-object></p><p><related-object content-type="generated-dataset" id="dataset3" source-id="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE56869" source-id-type="uri"><collab collab-type="author">Ma W</collab><collab collab-type="author">Ay F</collab><collab collab-type="author">Lee C</collab><collab collab-type="author">Gulsoy G</collab><collab collab-type="author">Deng X</collab><collab collab-type="author">Cook S</collab><collab collab-type="author">Hesson J</collab><collab collab-type="author">Ware CB</collab><collab collab-type="author">Krumm A</collab><collab collab-type="author">Shendure J</collab><collab collab-type="author">Blau CA</collab><collab collab-type="author">Disteche C</collab><collab collab-type="author">Noble WS</collab><collab collab-type="author">Duan Z</collab><year>2014</year><source>Fine-scale chromatin interaction maps reveal the cis-regulatory landscape of human lincRNA genes</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE56869">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE56869</ext-link><comment>Publicly available at the NCBI Gene Expression Omnibus (accession no: GSE56869)</comment></related-object></p><p><related-object content-type="generated-dataset" id="dataset4" source-id="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE27584" source-id-type="uri"><collab collab-type="author">Varley K</collab><collab collab-type="author">Gertz J</collab><collab collab-type="author">Myers RM</collab><year>2011</year><source>DNA Methylation by Reduced Representation Bisulfite Seq from ENCODE/HudsonAlpha</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE27584">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE27584</ext-link><comment>Publicly available at the NCBI Gene Expression Omnibus (accession no: GSE27584)</comment></related-object></p><p><related-object content-type="generated-dataset" id="dataset5" source-id="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE57628" source-id-type="uri"><collab collab-type="author">Baranello L</collab><collab collab-type="author">Wojtowicz D</collab><collab collab-type="author">Kouzine F</collab><collab collab-type="author">Cui K</collab><collab collab-type="author">Chan-Salis KY</collab><collab collab-type="author">Devaiah BN</collab><collab collab-type="author">Singer D</collab><collab collab-type="author">Pommier Y</collab><collab collab-type="author">Pugh BF</collab><collab collab-type="author">Przytycka TM</collab><collab collab-type="author">Lewis BA</collab><collab collab-type="author">Zhao K</collab><collab collab-type="author">Levens D</collab><year>2016</year><source>Study of Topoisomerase I in human</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE57628">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE57628</ext-link><comment>Publicly available at the NCBI Gene Expression Omnibus (accession no: GSE57628)</comment></related-object></p><p><related-object content-type="generated-dataset" id="dataset6" source-id="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE32970" source-id-type="uri"><collab collab-type="author">Furey T</collab><collab collab-type="author">Boyle A</collab><collab collab-type="author">Song L</collab><collab collab-type="author">Crawford G</collab><collab collab-type="author">Giresi P</collab><collab collab-type="author">Lieb J</collab><collab collab-type="author">Liu Z</collab><collab collab-type="author">McDaniell R</collab><collab collab-type="author">Lee B</collab><collab collab-type="author">Iyer V</collab><collab collab-type="author">Flicek P</collab><collab collab-type="author">Keefe D</collab><collab collab-type="author">Birney E</collab><collab collab-type="author">Graf S</collab><year>2011</year><source>Open Chromatin by DNaseI HS from ENCODE/OpenChrom(Duke University)</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE32970">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE32970</ext-link><comment>Publicly available at the NCBI Gene Expression Omnibus (accession no: GSE32970)</comment></related-object></p><p><related-object content-type="generated-dataset" id="dataset7" source-id="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE45803" source-id-type="uri"><collab collab-type="author">Rouskin S</collab><collab collab-type="author">Zubradt M</collab><collab collab-type="author">Washietl S</collab><collab collab-type="author">Kellis M</collab><collab collab-type="author">Weissman JS</collab><year>2013</year><source>Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE45803">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE45803</ext-link><comment>Publicly available at the NCBI Gene Expression Omnibus (accession no: GSE45803)</comment></related-object></p><p><related-object content-type="generated-dataset" id="dataset8" source-id="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE29692" source-id-type="uri"><collab collab-type="author">Sandstrom R</collab><year>2011</year><source>DNaseI Hypersensitivity by Digital DNaseI from ENCODE/University of Washington</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE29692">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE29692</ext-link><comment>Publicly available at the NCBI Gene Expression Omnibus (accession no: GSE29692)</comment></related-object></p><p><related-object content-type="generated-dataset" id="dataset9" source-id="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE31477" source-id-type="uri"><collab collab-type="author">Snyder M</collab><collab collab-type="author">Gerstein M</collab><collab collab-type="author">Weissman S</collab><collab collab-type="author">Farnham P</collab><collab collab-type="author">Struhl K</collab><year>2011</year><source>ENCODE Transcription Factor Binding Sites by ChIP-seq from Stanford/Yale/USC/Harvard</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE31477">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE31477</ext-link><comment>Publicly available at the NCBI Gene Expression Omnibus (accession no: GSE31477)</comment></related-object></p><p><related-object content-type="generated-dataset" id="dataset10" source-id="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE52914" source-id-type="uri"><collab collab-type="author">Descostes N</collab><collab collab-type="author">Heidemann M</collab><collab collab-type="author">Spinelli L</collab><collab collab-type="author">Schüller R</collab><collab collab-type="author">Maqbool MA</collab><collab collab-type="author">Fenouil R</collab><collab collab-type="author">Koch F</collab><collab collab-type="author">Innocenti C</collab><collab collab-type="author">Gut M</collab><collab collab-type="author">Gut I</collab><collab collab-type="author">Eick D</collab><collab collab-type="author">Andrau J</collab><year>2014</year><source>Tyrosine phosphorylation of RNA Polymerase II CTD is associated with antisense promoter transcription and active enhancers in mammalian cells</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE52914">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE52914</ext-link><comment>Publicly available at the NCBI Gene Expression Omnibus (accession no: GSE52914)</comment></related-object></p><p><related-object content-type="generated-dataset" id="dataset11" source-id="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE51633" source-id-type="uri"><collab collab-type="author">Liu W</collab><collab collab-type="author">Ma Q</collab><year>2014</year><source>Brd4 and JMJD6-associated Anti-pause Enhancers in Regulation of Transcriptional Pause Release</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE51633">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE51633</ext-link><comment>Publicly available at the NCBI Gene Expression Omnibus (accession no: GSE51633)</comment></related-object></p><p><related-object content-type="generated-dataset" id="dataset12" source-id="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE70408" source-id-type="uri"><collab collab-type="author">Chen F</collab><collab collab-type="author">Woodfin AR</collab><collab collab-type="author">Shilatifard A</collab><year>2015</year><source>PAF1, a molecular regulator of promoter-proximal pausing by RNA Polymerase II</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE70408">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE70408</ext-link><comment>Publicly available at the NCBI Gene Expression Omnibus (accession no: GSE70408)</comment></related-object></p></sec></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anders</surname> <given-names>S</given-names></name><name><surname>Huber</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Differential expression analysis for sequence count data</article-title><source>Genome Biology</source><volume>11</volume><elocation-id>R106</elocation-id><pub-id pub-id-type="doi">10.1186/gb-2010-11-10-r106</pub-id><pub-id pub-id-type="pmid">20979621</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anders</surname> <given-names>S</given-names></name><name><surname>Pyl</surname> <given-names>PT</given-names></name><name><surname>Huber</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>HTSeq--a Python framework to work with high-throughput sequencing data</article-title><source>Bioinformatics</source><volume>31</volume><fpage>166</fpage><lpage>169</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btu638</pub-id><pub-id pub-id-type="pmid">25260700</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baranello</surname> <given-names>L</given-names></name><name><surname>Wojtowicz</surname> <given-names>D</given-names></name><name><surname>Cui</surname> <given-names>K</given-names></name><name><surname>Devaiah</surname> <given-names>BN</given-names></name><name><surname>Chung</surname> <given-names>HJ</given-names></name><name><surname>Chan-Salis</surname> <given-names>KY</given-names></name><name><surname>Guha</surname> <given-names>R</given-names></name><name><surname>Wilson</surname> <given-names>K</given-names></name><name><surname>Zhang</surname> <given-names>X</given-names></name><name><surname>Zhang</surname> <given-names>H</given-names></name><name><surname>Piotrowski</surname> <given-names>J</given-names></name><name><surname>Thomas</surname> <given-names>CJ</given-names></name><name><surname>Singer</surname> <given-names>DS</given-names></name><name><surname>Pugh</surname> <given-names>BF</given-names></name><name><surname>Pommier</surname> <given-names>Y</given-names></name><name><surname>Przytycka</surname> <given-names>TM</given-names></name><name><surname>Kouzine</surname> <given-names>F</given-names></name><name><surname>Lewis</surname> <given-names>BA</given-names></name><name><surname>Zhao</surname> <given-names>K</given-names></name><name><surname>Levens</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>RNA polymerase ii regulates topoisomerase 1 activity to favor efficient transcription</article-title><source>Cell</source><volume>165</volume><fpage>357</fpage><lpage>371</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.02.036</pub-id><pub-id pub-id-type="pmid">27058666</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boehm</surname> <given-names>AK</given-names></name><name><surname>Saunders</surname> <given-names>A</given-names></name><name><surname>Werner</surname> <given-names>J</given-names></name><name><surname>Lis</surname> <given-names>JT</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Transcription factor and polymerase recruitment, modification, and movement on dhsp70 in vivo in the minutes following heat shock</article-title><source>Molecular and Cellular Biology</source><volume>23</volume><fpage>7628</fpage><lpage>7637</lpage><pub-id pub-id-type="doi">10.1128/MCB.23.21.7628-7637.2003</pub-id><pub-id pub-id-type="pmid">14560008</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buckley</surname> <given-names>MS</given-names></name><name><surname>Kwak</surname> <given-names>H</given-names></name><name><surname>Zipfel</surname> <given-names>WR</given-names></name><name><surname>Lis</surname> <given-names>JT</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Kinetics of promoter Pol II on Hsp70 reveal stable pausing and key insights into its regulation</article-title><source>Genes &amp; Development</source><volume>28</volume><fpage>14</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1101/gad.231886.113</pub-id><pub-id pub-id-type="pmid">24395245</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>FX</given-names></name><name><surname>Woodfin</surname> <given-names>AR</given-names></name><name><surname>Gardini</surname> <given-names>A</given-names></name><name><surname>Rickels</surname> <given-names>RA</given-names></name><name><surname>Marshall</surname> <given-names>SA</given-names></name><name><surname>Smith</surname> <given-names>ER</given-names></name><name><surname>Shiekhattar</surname> <given-names>R</given-names></name><name><surname>Shilatifard</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>PAF1, a molecular regulator of promoter-proximal pausing by rna polymerase II</article-title><source>Cell</source><volume>162</volume><fpage>1003</fpage><lpage>1015</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2015.07.042</pub-id><pub-id pub-id-type="pmid">26279188</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conrad</surname> <given-names>T</given-names></name><name><surname>Ørom</surname> <given-names>UA</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Cellular fractionation and isolation of chromatin-associated RNA</article-title><source>Methods in molecular biology</source><volume>1468</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1007/978-1-4939-4035-6_1</pub-id><pub-id pub-id-type="pmid">27662865</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Core</surname> <given-names>LJ</given-names></name><name><surname>Waterfall</surname> <given-names>JJ</given-names></name><name><surname>Lis</surname> <given-names>JT</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Nascent RNA sequencing reveals widespread pausing and divergent initiation at human promoters</article-title><source>Science</source><volume>322</volume><fpage>1845</fpage><lpage>1848</lpage><pub-id pub-id-type="doi">10.1126/science.1162228</pub-id><pub-id pub-id-type="pmid">19056941</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Day</surname> <given-names>DS</given-names></name><name><surname>Zhang</surname> <given-names>B</given-names></name><name><surname>Stevens</surname> <given-names>SM</given-names></name><name><surname>Ferrari</surname> <given-names>F</given-names></name><name><surname>Larschan</surname> <given-names>EN</given-names></name><name><surname>Park</surname> <given-names>PJ</given-names></name><name><surname>Pu</surname> <given-names>WT</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Comprehensive analysis of promoter-proximal RNA polymerase II pausing across mammalian cell types</article-title><source>Genome Biology</source><volume>17</volume><elocation-id>120</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-016-0984-2</pub-id><pub-id pub-id-type="pmid">27259512</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Descostes</surname> <given-names>N</given-names></name><name><surname>Heidemann</surname> <given-names>M</given-names></name><name><surname>Spinelli</surname> <given-names>L</given-names></name><name><surname>Schüller</surname> <given-names>R</given-names></name><name><surname>Maqbool</surname> <given-names>MA</given-names></name><name><surname>Fenouil</surname> <given-names>R</given-names></name><name><surname>Koch</surname> <given-names>F</given-names></name><name><surname>Innocenti</surname> <given-names>C</given-names></name><name><surname>Gut</surname> <given-names>M</given-names></name><name><surname>Gut</surname> <given-names>I</given-names></name><name><surname>Eick</surname> <given-names>D</given-names></name><name><surname>Andrau</surname> <given-names>JC</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Tyrosine phosphorylation of RNA polymerase II CTD is associated with antisense promoter transcription and active enhancers in mammalian cells</article-title><source>eLife</source><volume>3</volume><elocation-id>e02105</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.02105</pub-id><pub-id pub-id-type="pmid">24842994</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dobin</surname> <given-names>A</given-names></name><name><surname>Gingeras</surname> <given-names>TR</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Mapping RNA-seq reads with star</article-title><source>Current protocols in bioinformatics</source><volume>51</volume><fpage>11</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1002/0471250953.bi1114s51</pub-id><pub-id pub-id-type="pmid">26334920</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doudna</surname> <given-names>JA</given-names></name><name><surname>Charpentier</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Genome editing. The new frontier of genome engineering with CRISPR-Cas9</article-title><source>Science</source><volume>346</volume><elocation-id>1258096</elocation-id><pub-id pub-id-type="doi">10.1126/science.1258096</pub-id><pub-id pub-id-type="pmid">25430774</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ehrensberger</surname> <given-names>AH</given-names></name><name><surname>Kelly</surname> <given-names>GP</given-names></name><name><surname>Svejstrup</surname> <given-names>JQ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Mechanistic interpretation of promoter-proximal peaks and RNAPII density maps</article-title><source>Cell</source><volume>154</volume><fpage>713</fpage><lpage>715</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2013.07.032</pub-id><pub-id pub-id-type="pmid">23953103</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><collab>ENCODE Project Consortium</collab></person-group><year iso-8601-date="2012">2012</year><article-title>An integrated encyclopedia of DNA elements in the human genome</article-title><source>Nature</source><volume>489</volume><fpage>57</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1038/nature11247</pub-id><pub-id pub-id-type="pmid">22955616</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fuchs</surname> <given-names>G</given-names></name><name><surname>Voichek</surname> <given-names>Y</given-names></name><name><surname>Benjamin</surname> <given-names>S</given-names></name><name><surname>Gilad</surname> <given-names>S</given-names></name><name><surname>Amit</surname> <given-names>I</given-names></name><name><surname>Oren</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>4sUDRB-seq: measuring genomewide transcriptional elongation rates and initiation frequencies within cells</article-title><source>Genome Biology</source><volume>15</volume><elocation-id>R69</elocation-id><pub-id pub-id-type="doi">10.1186/gb-2014-15-5-r69</pub-id><pub-id pub-id-type="pmid">24887486</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghavi-Helm</surname> <given-names>Y</given-names></name><name><surname>Klein</surname> <given-names>FA</given-names></name><name><surname>Pakozdi</surname> <given-names>T</given-names></name><name><surname>Ciglar</surname> <given-names>L</given-names></name><name><surname>Noordermeer</surname> <given-names>D</given-names></name><name><surname>Huber</surname> <given-names>W</given-names></name><name><surname>Furlong</surname> <given-names>EE</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Enhancer loops appear stable during development and are associated with paused polymerase</article-title><source>Nature</source><volume>512</volume><fpage>96</fpage><lpage>100</lpage><pub-id pub-id-type="doi">10.1038/nature13417</pub-id><pub-id pub-id-type="pmid">25043061</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname> <given-names>Y</given-names></name><name><surname>Yan</surname> <given-names>C</given-names></name><name><surname>Fang</surname> <given-names>J</given-names></name><name><surname>Inouye</surname> <given-names>C</given-names></name><name><surname>Tjian</surname> <given-names>R</given-names></name><name><surname>Ivanov</surname> <given-names>I</given-names></name><name><surname>Nogales</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Near-atomic resolution visualization of human transcription promoter opening</article-title><source>Nature</source><volume>533</volume><fpage>359</fpage><lpage>365</lpage><pub-id pub-id-type="doi">10.1038/nature17970</pub-id><pub-id pub-id-type="pmid">27193682</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hendrix</surname> <given-names>DA</given-names></name><name><surname>Hong</surname> <given-names>JW</given-names></name><name><surname>Zeitlinger</surname> <given-names>J</given-names></name><name><surname>Rokhsar</surname> <given-names>DS</given-names></name><name><surname>Levine</surname> <given-names>MS</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Promoter elements associated with RNA Pol II stalling in the Drosophila embryo</article-title><source>PNAS</source><volume>105</volume><fpage>7762</fpage><lpage>7767</lpage><pub-id pub-id-type="doi">10.1073/pnas.0802406105</pub-id><pub-id pub-id-type="pmid">18505835</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henriques</surname> <given-names>T</given-names></name><name><surname>Gilchrist</surname> <given-names>DA</given-names></name><name><surname>Nechaev</surname> <given-names>S</given-names></name><name><surname>Bern</surname> <given-names>M</given-names></name><name><surname>Muse</surname> <given-names>GW</given-names></name><name><surname>Burkholder</surname> <given-names>A</given-names></name><name><surname>Fargo</surname> <given-names>DC</given-names></name><name><surname>Adelman</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Stable pausing by RNA polymerase II provides an opportunity to target and integrate regulatory signals</article-title><source>Molecular Cell</source><volume>52</volume><fpage>517</fpage><lpage>528</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2013.10.001</pub-id><pub-id pub-id-type="pmid">24184211</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsu</surname> <given-names>PD</given-names></name><name><surname>Lander</surname> <given-names>ES</given-names></name><name><surname>Zhang</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Development and applications of CRISPR-Cas9 for genome engineering</article-title><source>Cell</source><volume>157</volume><fpage>1262</fpage><lpage>1278</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2014.05.010</pub-id><pub-id pub-id-type="pmid">24906146</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname> <given-names>DS</given-names></name><name><surname>Mortazavi</surname> <given-names>A</given-names></name><name><surname>Myers</surname> <given-names>RM</given-names></name><name><surname>Wold</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Genome-wide mapping of in vivo protein-DNA interactions</article-title><source>Science</source><volume>316</volume><fpage>1497</fpage><lpage>1502</lpage><pub-id pub-id-type="doi">10.1126/science.1141319</pub-id><pub-id pub-id-type="pmid">17540862</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jonkers</surname> <given-names>I</given-names></name><name><surname>Kwak</surname> <given-names>H</given-names></name><name><surname>Lis</surname> <given-names>JT</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Genome-wide dynamics of Pol II elongation and its interplay with promoter proximal pausing, chromatin, and exons</article-title><source>eLife</source><volume>3</volume><elocation-id>e02407</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.02407</pub-id><pub-id pub-id-type="pmid">24843027</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kettenberger</surname> <given-names>H</given-names></name><name><surname>Armache</surname> <given-names>KJ</given-names></name><name><surname>Cramer</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Complete RNA polymerase II elongation complex structure and its interactions with NTP and TFIIS</article-title><source>Molecular Cell</source><volume>16</volume><fpage>955</fpage><lpage>965</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2004.11.040</pub-id><pub-id pub-id-type="pmid">15610738</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kireeva</surname> <given-names>ML</given-names></name><name><surname>Komissarova</surname> <given-names>N</given-names></name><name><surname>Waugh</surname> <given-names>DS</given-names></name><name><surname>Kashlev</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>The 8-nucleotide-long RNA:DNA hybrid is a primary stability determinant of the RNA polymerase II elongation complex</article-title><source>Journal of Biological Chemistry</source><volume>275</volume><fpage>6530</fpage><lpage>6536</lpage><pub-id pub-id-type="doi">10.1074/jbc.275.9.6530</pub-id><pub-id pub-id-type="pmid">10692458</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwak</surname> <given-names>H</given-names></name><name><surname>Fuda</surname> <given-names>NJ</given-names></name><name><surname>Core</surname> <given-names>LJ</given-names></name><name><surname>Lis</surname> <given-names>JT</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Precise maps of RNA polymerase reveal how promoters direct initiation and pausing</article-title><source>Science</source><volume>339</volume><fpage>950</fpage><lpage>953</lpage><pub-id pub-id-type="doi">10.1126/science.1229386</pub-id><pub-id pub-id-type="pmid">23430654</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laitem</surname> <given-names>C</given-names></name><name><surname>Zaborowska</surname> <given-names>J</given-names></name><name><surname>Isa</surname> <given-names>NF</given-names></name><name><surname>Kufs</surname> <given-names>J</given-names></name><name><surname>Dienstbier</surname> <given-names>M</given-names></name><name><surname>Murphy</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>CDK9 inhibitors define elongation checkpoints at both ends of RNA polymerase II-transcribed genes</article-title><source>Nature Structural &amp; Molecular Biology</source><volume>22</volume><fpage>396</fpage><lpage>403</lpage><pub-id pub-id-type="doi">10.1038/nsmb.3000</pub-id><pub-id pub-id-type="pmid">25849141</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>H</given-names></name><name><surname>Handsaker</surname> <given-names>B</given-names></name><name><surname>Wysoker</surname> <given-names>A</given-names></name><name><surname>Fennell</surname> <given-names>T</given-names></name><name><surname>Ruan</surname> <given-names>J</given-names></name><name><surname>Homer</surname> <given-names>N</given-names></name><name><surname>Marth</surname> <given-names>G</given-names></name><name><surname>Abecasis</surname> <given-names>G</given-names></name><name><surname>Durbin</surname> <given-names>R</given-names></name><collab>1000 Genome Project Data Processing Subgroup</collab></person-group><year iso-8601-date="2009">2009</year><article-title>The sequence alignment/map format and samtools</article-title><source>Bioinformatics</source><volume>25</volume><fpage>2078</fpage><lpage>2079</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btp352</pub-id><pub-id pub-id-type="pmid">19505943</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>W</given-names></name><name><surname>Ma</surname> <given-names>Q</given-names></name><name><surname>Wong</surname> <given-names>K</given-names></name><name><surname>Li</surname> <given-names>W</given-names></name><name><surname>Ohgi</surname> <given-names>K</given-names></name><name><surname>Zhang</surname> <given-names>J</given-names></name><name><surname>Aggarwal</surname> <given-names>A</given-names></name><name><surname>Rosenfeld</surname> <given-names>MG</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Brd4 and JMJD6-associated anti-pause enhancers in regulation of transcriptional pause release</article-title><source>Cell</source><volume>155</volume><fpage>1581</fpage><lpage>1595</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2013.10.056</pub-id><pub-id pub-id-type="pmid">24360279</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopez</surname> <given-names>MS</given-names></name><name><surname>Kliegman</surname> <given-names>JI</given-names></name><name><surname>Shokat</surname> <given-names>KM</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The logic and design of analog-sensitive kinases and their small molecule inhibitors</article-title><source>Methods in enzymology</source><volume>548</volume><fpage>189</fpage><lpage>213</lpage><pub-id pub-id-type="doi">10.1016/B978-0-12-397918-6.00008-2</pub-id><pub-id pub-id-type="pmid">25399647</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lorenz</surname> <given-names>R</given-names></name><name><surname>Bernhart</surname> <given-names>SH</given-names></name><name><surname>Höner Zu Siederdissen</surname> <given-names>C</given-names></name><name><surname>Tafer</surname> <given-names>H</given-names></name><name><surname>Flamm</surname> <given-names>C</given-names></name><name><surname>Stadler</surname> <given-names>PF</given-names></name><name><surname>Hofacker</surname> <given-names>IL</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>ViennaRNA package 2.0</article-title><source>Algorithms for Molecular Biology</source><volume>6</volume><fpage>26</fpage><pub-id pub-id-type="doi">10.1186/1748-7188-6-26</pub-id><pub-id pub-id-type="pmid">22115189</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Louder</surname> <given-names>RK</given-names></name><name><surname>He</surname> <given-names>Y</given-names></name><name><surname>López-Blanco</surname> <given-names>JR</given-names></name><name><surname>Fang</surname> <given-names>J</given-names></name><name><surname>Chacón</surname> <given-names>P</given-names></name><name><surname>Nogales</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Structure of promoter-bound TFIID and model of human pre-initiation complex assembly</article-title><source>Nature</source><volume>531</volume><fpage>604</fpage><lpage>609</lpage><pub-id pub-id-type="doi">10.1038/nature17394</pub-id><pub-id pub-id-type="pmid">27007846</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname> <given-names>W</given-names></name><name><surname>Ay</surname> <given-names>F</given-names></name><name><surname>Lee</surname> <given-names>C</given-names></name><name><surname>Gulsoy</surname> <given-names>G</given-names></name><name><surname>Deng</surname> <given-names>X</given-names></name><name><surname>Cook</surname> <given-names>S</given-names></name><name><surname>Hesson</surname> <given-names>J</given-names></name><name><surname>Cavanaugh</surname> <given-names>C</given-names></name><name><surname>Ware</surname> <given-names>CB</given-names></name><name><surname>Krumm</surname> <given-names>A</given-names></name><name><surname>Shendure</surname> <given-names>J</given-names></name><name><surname>Blau</surname> <given-names>CA</given-names></name><name><surname>Disteche</surname> <given-names>CM</given-names></name><name><surname>Noble</surname> <given-names>WS</given-names></name><name><surname>Duan</surname> <given-names>Z</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Fine-scale chromatin interaction maps reveal the cis-regulatory landscape of human lincRNA genes</article-title><source>Nature Methods</source><volume>12</volume><fpage>71</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.1038/nmeth.3205</pub-id><pub-id pub-id-type="pmid">25437436</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marshall</surname> <given-names>NF</given-names></name><name><surname>Price</surname> <given-names>DH</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Control of formation of two distinct classes of RNA polymerase II elongation complexes</article-title><source>Molecular and Cellular Biology</source><volume>12</volume><fpage>2078</fpage><lpage>2090</lpage><pub-id pub-id-type="doi">10.1128/MCB.12.5.2078</pub-id><pub-id pub-id-type="pmid">1569941</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayer</surname> <given-names>A</given-names></name><name><surname>di Iulio</surname> <given-names>J</given-names></name><name><surname>Maleri</surname> <given-names>S</given-names></name><name><surname>Eser</surname> <given-names>U</given-names></name><name><surname>Vierstra</surname> <given-names>J</given-names></name><name><surname>Reynolds</surname> <given-names>A</given-names></name><name><surname>Sandstrom</surname> <given-names>R</given-names></name><name><surname>Stamatoyannopoulos</surname> <given-names>JA</given-names></name><name><surname>Churchman</surname> <given-names>LS</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Native elongating transcript sequencing reveals human transcriptional activity at nucleotide resolution</article-title><source>Cell</source><volume>161</volume><fpage>541</fpage><lpage>554</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2015.03.010</pub-id><pub-id pub-id-type="pmid">25910208</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morales</surname> <given-names>F</given-names></name><name><surname>Giordano</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Overview of CDK9 as a target in cancer research</article-title><source>Cell Cycle</source><volume>15</volume><fpage>519</fpage><lpage>527</lpage><pub-id pub-id-type="doi">10.1080/15384101.2016.1138186</pub-id><pub-id pub-id-type="pmid">26766294</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mulholland</surname> <given-names>CB</given-names></name><name><surname>Smets</surname> <given-names>M</given-names></name><name><surname>Schmidtmann</surname> <given-names>E</given-names></name><name><surname>Leidescher</surname> <given-names>S</given-names></name><name><surname>Markaki</surname> <given-names>Y</given-names></name><name><surname>Hofweber</surname> <given-names>M</given-names></name><name><surname>Qin</surname> <given-names>W</given-names></name><name><surname>Manzo</surname> <given-names>M</given-names></name><name><surname>Kremmer</surname> <given-names>E</given-names></name><name><surname>Thanisch</surname> <given-names>K</given-names></name><name><surname>Bauer</surname> <given-names>C</given-names></name><name><surname>Rombaut</surname> <given-names>P</given-names></name><name><surname>Herzog</surname> <given-names>F</given-names></name><name><surname>Leonhardt</surname> <given-names>H</given-names></name><name><surname>Bultmann</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>A modular open platform for systematic functional studies under physiological conditions</article-title><source>Nucleic Acids Research</source><volume>43</volume><elocation-id>e112</elocation-id><pub-id pub-id-type="doi">10.1093/nar/gkv550</pub-id><pub-id pub-id-type="pmid">26007658</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nechaev</surname> <given-names>S</given-names></name><name><surname>Fargo</surname> <given-names>DC</given-names></name><name><surname>dos Santos</surname> <given-names>G</given-names></name><name><surname>Liu</surname> <given-names>L</given-names></name><name><surname>Gao</surname> <given-names>Y</given-names></name><name><surname>Adelman</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Global analysis of short RNAs reveals widespread promoter-proximal stalling and arrest of Pol II in Drosophila</article-title><source>Science</source><volume>327</volume><fpage>335</fpage><lpage>338</lpage><pub-id pub-id-type="doi">10.1126/science.1181421</pub-id><pub-id pub-id-type="pmid">20007866</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nojima</surname> <given-names>T</given-names></name><name><surname>Gomes</surname> <given-names>T</given-names></name><name><surname>Carmo-Fonseca</surname> <given-names>M</given-names></name><name><surname>Proudfoot</surname> <given-names>NJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Mammalian NET-seq analysis defines nascent RNA profiles and associated RNA processing genome-wide</article-title><source>Nature Protocols</source><volume>11</volume><fpage>413</fpage><lpage>428</lpage><pub-id pub-id-type="doi">10.1038/nprot.2016.012</pub-id><pub-id pub-id-type="pmid">26844429</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nojima</surname> <given-names>T</given-names></name><name><surname>Gomes</surname> <given-names>T</given-names></name><name><surname>Grosso</surname> <given-names>ARF</given-names></name><name><surname>Kimura</surname> <given-names>H</given-names></name><name><surname>Dye</surname> <given-names>MJ</given-names></name><name><surname>Dhir</surname> <given-names>S</given-names></name><name><surname>Carmo-Fonseca</surname> <given-names>M</given-names></name><name><surname>Proudfoot</surname> <given-names>NJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Mammalian NET-seq reveals genome-wide nascent transcription coupled to RNA processing</article-title><source>Cell</source><volume>161</volume><fpage>526</fpage><lpage>540</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2015.03.027</pub-id><pub-id pub-id-type="pmid">25910207</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peterlin</surname> <given-names>BM</given-names></name><name><surname>Price</surname> <given-names>DH</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Controlling the elongation phase of transcription with P-TEFb</article-title><source>Molecular Cell</source><volume>23</volume><fpage>297</fpage><lpage>305</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2006.06.014</pub-id><pub-id pub-id-type="pmid">16885020</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plaschka</surname> <given-names>C</given-names></name><name><surname>Hantsche</surname> <given-names>M</given-names></name><name><surname>Dienemann</surname> <given-names>C</given-names></name><name><surname>Burzinski</surname> <given-names>C</given-names></name><name><surname>Plitzko</surname> <given-names>J</given-names></name><name><surname>Cramer</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Transcription initiation complex structures elucidate DNA opening</article-title><source>Nature</source><volume>533</volume><fpage>353</fpage><lpage>358</lpage><pub-id pub-id-type="doi">10.1038/nature17990</pub-id><pub-id pub-id-type="pmid">27193681</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rahl</surname> <given-names>PB</given-names></name><name><surname>Lin</surname> <given-names>CY</given-names></name><name><surname>Seila</surname> <given-names>AC</given-names></name><name><surname>Flynn</surname> <given-names>RA</given-names></name><name><surname>McCuine</surname> <given-names>S</given-names></name><name><surname>Burge</surname> <given-names>CB</given-names></name><name><surname>Sharp</surname> <given-names>PA</given-names></name><name><surname>Young</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>c-Myc regulates transcriptional pause release</article-title><source>Cell</source><volume>141</volume><fpage>432</fpage><lpage>445</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2010.03.030</pub-id><pub-id pub-id-type="pmid">20434984</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ran</surname> <given-names>FA</given-names></name><name><surname>Hsu</surname> <given-names>PD</given-names></name><name><surname>Wright</surname> <given-names>J</given-names></name><name><surname>Agarwala</surname> <given-names>V</given-names></name><name><surname>Scott</surname> <given-names>DA</given-names></name><name><surname>Zhang</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Genome engineering using the CRISPR-Cas9 system</article-title><source>Nature Protocols</source><volume>8</volume><fpage>2281</fpage><lpage>2308</lpage><pub-id pub-id-type="doi">10.1038/nprot.2013.143</pub-id><pub-id pub-id-type="pmid">24157548</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname> <given-names>PJ</given-names></name><name><surname>Trnka</surname> <given-names>MJ</given-names></name><name><surname>Bushnell</surname> <given-names>DA</given-names></name><name><surname>Davis</surname> <given-names>RE</given-names></name><name><surname>Mattei</surname> <given-names>PJ</given-names></name><name><surname>Burlingame</surname> <given-names>AL</given-names></name><name><surname>Kornberg</surname> <given-names>RD</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Structure of a complete mediator-RNA polymerase ii pre-initiation complex</article-title><source>Cell</source><volume>166</volume><fpage>1411</fpage><lpage>1422</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.08.050</pub-id><pub-id pub-id-type="pmid">27610567</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rougvie</surname> <given-names>AE</given-names></name><name><surname>Lis</surname> <given-names>JT</given-names></name></person-group><year iso-8601-date="1988">1988</year><article-title>The RNA polymerase II molecule at the 5' end of the uninduced hsp70 gene of D. melanogaster is transcriptionally engaged</article-title><source>Cell</source><volume>54</volume><fpage>795</fpage><lpage>804</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(88)91087-2</pub-id><pub-id pub-id-type="pmid">3136931</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rouskin</surname> <given-names>S</given-names></name><name><surname>Zubradt</surname> <given-names>M</given-names></name><name><surname>Washietl</surname> <given-names>S</given-names></name><name><surname>Kellis</surname> <given-names>M</given-names></name><name><surname>Weissman</surname> <given-names>JS</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo</article-title><source>Nature</source><volume>505</volume><fpage>701</fpage><lpage>705</lpage><pub-id pub-id-type="doi">10.1038/nature12894</pub-id><pub-id pub-id-type="pmid">24336214</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>SantaLucia</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>A unified view of polymer, dumbbell, and oligonucleotide DNA nearest-neighbor thermodynamics</article-title><source>PNAS</source><volume>95</volume><fpage>1460</fpage><lpage>1465</lpage><pub-id pub-id-type="doi">10.1073/pnas.95.4.1460</pub-id><pub-id pub-id-type="pmid">9465037</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saponaro</surname> <given-names>M</given-names></name><name><surname>Kantidakis</surname> <given-names>T</given-names></name><name><surname>Mitter</surname> <given-names>R</given-names></name><name><surname>Kelly</surname> <given-names>GP</given-names></name><name><surname>Heron</surname> <given-names>M</given-names></name><name><surname>Williams</surname> <given-names>H</given-names></name><name><surname>Söding</surname> <given-names>J</given-names></name><name><surname>Stewart</surname> <given-names>A</given-names></name><name><surname>Svejstrup</surname> <given-names>JQ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>RECQL5 controls transcript elongation and suppresses genome instability associated with transcription stress</article-title><source>Cell</source><volume>157</volume><fpage>1037</fpage><lpage>1049</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2014.03.048</pub-id><pub-id pub-id-type="pmid">24836610</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schlackow</surname> <given-names>M</given-names></name><name><surname>Nojima</surname> <given-names>T</given-names></name><name><surname>Gomes</surname> <given-names>T</given-names></name><name><surname>Dhir</surname> <given-names>A</given-names></name><name><surname>Carmo-Fonseca</surname> <given-names>M</given-names></name><name><surname>Proudfoot</surname> <given-names>NJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Distinctive patterns of transcription and RNA processing for human lincRNAs</article-title><source>Molecular Cell</source><volume>65</volume><fpage>25</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2016.11.029</pub-id><pub-id pub-id-type="pmid">28017589</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwalb</surname> <given-names>B</given-names></name><name><surname>Michel</surname> <given-names>M</given-names></name><name><surname>Zacher</surname> <given-names>B</given-names></name><name><surname>Frühauf</surname> <given-names>K</given-names></name><name><surname>Demel</surname> <given-names>C</given-names></name><name><surname>Tresch</surname> <given-names>A</given-names></name><name><surname>Gagneur</surname> <given-names>J</given-names></name><name><surname>Cramer</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>TT-seq maps the human transient transcriptome</article-title><source>Science</source><volume>352</volume><fpage>1225</fpage><lpage>1228</lpage><pub-id pub-id-type="doi">10.1126/science.aad9841</pub-id><pub-id pub-id-type="pmid">27257258</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shao</surname> <given-names>W</given-names></name><name><surname>Zeitlinger</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Paused RNA polymerase II inhibits new transcriptional initiation</article-title><source>Nature Genetics</source><volume>49</volume><fpage>1045</fpage><lpage>1051</lpage><pub-id pub-id-type="doi">10.1038/ng.3867</pub-id><pub-id pub-id-type="pmid">28504701</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sievers</surname> <given-names>F</given-names></name><name><surname>Wilm</surname> <given-names>A</given-names></name><name><surname>Dineen</surname> <given-names>D</given-names></name><name><surname>Gibson</surname> <given-names>TJ</given-names></name><name><surname>Karplus</surname> <given-names>K</given-names></name><name><surname>Li</surname> <given-names>W</given-names></name><name><surname>Lopez</surname> <given-names>R</given-names></name><name><surname>McWilliam</surname> <given-names>H</given-names></name><name><surname>Remmert</surname> <given-names>M</given-names></name><name><surname>Söding</surname> <given-names>J</given-names></name><name><surname>Thompson</surname> <given-names>JD</given-names></name><name><surname>Higgins</surname> <given-names>DG</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega</article-title><source>Molecular Systems Biology</source><volume>7</volume><elocation-id>539</elocation-id><pub-id pub-id-type="doi">10.1038/msb.2011.75</pub-id><pub-id pub-id-type="pmid">21988835</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strobl</surname> <given-names>LJ</given-names></name><name><surname>Eick</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Hold back of RNA polymerase II at the transcription start site mediates down-regulation of c-myc in vivo</article-title><source>The EMBO Journal</source><volume>11</volume><fpage>3307</fpage><lpage>3314</lpage><pub-id pub-id-type="pmid">1505520</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sugimoto</surname> <given-names>N</given-names></name><name><surname>Nakano</surname> <given-names>S</given-names></name><name><surname>Katoh</surname> <given-names>M</given-names></name><name><surname>Matsumura</surname> <given-names>A</given-names></name><name><surname>Nakamuta</surname> <given-names>H</given-names></name><name><surname>Ohmichi</surname> <given-names>T</given-names></name><name><surname>Yoneyama</surname> <given-names>M</given-names></name><name><surname>Sasaki</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Thermodynamic parameters to predict stability of RNA/DNA hybrid duplexes</article-title><source>Biochemistry</source><volume>34</volume><fpage>11211</fpage><lpage>11216</lpage><pub-id pub-id-type="doi">10.1021/bi00035a029</pub-id><pub-id pub-id-type="pmid">7545436</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Veloso</surname> <given-names>A</given-names></name><name><surname>Kirkconnell</surname> <given-names>KS</given-names></name><name><surname>Magnuson</surname> <given-names>B</given-names></name><name><surname>Biewen</surname> <given-names>B</given-names></name><name><surname>Paulsen</surname> <given-names>MT</given-names></name><name><surname>Wilson</surname> <given-names>TE</given-names></name><name><surname>Ljungman</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Rate of elongation by RNA polymerase II is associated with specific gene features and epigenetic modifications</article-title><source>Genome Research</source><volume>24</volume><fpage>896</fpage><lpage>905</lpage><pub-id pub-id-type="doi">10.1101/gr.171405.113</pub-id><pub-id pub-id-type="pmid">24714810</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="SA1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.29736.043</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Jones</surname><given-names>Katherine A</given-names></name><role>Reviewing Editor</role><aff><institution>Salk Institute for Biological Studies</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.</p></boxed-text><p>Thank you for submitting your article &quot;CDK9-dependent RNA polymerase II pausing controls transcription initiation&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by three peer reviewers, one of whom is a member of our Board of Reviewing Editors and the evaluation has been overseen by Kevin Struhl as the Senior Editor. The reviewers have opted to remain anonymous.</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>In this manuscript, 4sU-seq and NET-seq were used in combination with an analogue-sensitive CDK9 mutant to investigate the relationship between transcriptional pausing and initiation. The reviewers agree that the findings definitively show that transcription initiation rates vary at strongly versus weakly paused RNA polymerase II promoters, and that inactivation of CDK9 thus affects transcription initiation, whether directly or indirectly, in a manner that correlates with pausing strength. The reviewers consider these conclusions extremely important and timely, and help explain how strongly paused genes can effectively and synchronously upregulate mRNA levels.</p><p>Comments are provided for revision:</p><p>1) Prior cell-free transcription experiments have shown large effects on mRNA synthesis due to pause-release under conditions that do not support enhancer-linked transcription initiation or chromatin templates to facilitate transcription reinitiation. The differences in pause frequency and strength between different promoters can also be recapitulated in vitro in the absence of long-range connections between enhancers or chromatin- the resulting changes in mRNA levels in these studies are quite large and P-TEFb/NELF-DSIF-dependent. Should the changes in initiation secondary to pausing observed here be more accurately described as indirect? Or would 4sU-seq and NET-seq reveal a stronger effect on initiation in these systems?</p><p>2) The authors should comment on the fact that the estimates for pause duration and initiation frequency in subsection “Multi-omics analysis provides pause duration <italic>d</italic> and initiation frequency <italic>I</italic>” disregard any differences there might be in transcriptional processivity between different genes and regions.</p><p>3) Why are the position-markers truncated in '<xref ref-type="fig" rid="fig1">Figure 1</xref>' and '<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>'? The rulers should cover the whole genomic area shown in the figure above.</p><p>4) Introduction: Consider inserting 'underlying' so the sentence reads: &quot;The mechanisms underlying how Pol II pausing can regulate…..&quot;</p><p>5) Cite Saponaro et al., 2014, who also published on elongation speeds using the techniques referenced in subsection “Pol II elongation velocity is gene-specific”.</p><p>6) The authors have not directly analyzed initiation or the formation of pre-initiation complexes as was done by Shao and Zeitlinger, 2017. As such, they should use the term &quot;pause release&quot; rather than 'initiation frequency' given that the data are focused on pol II release from the pausing site. 7)</p><p>7) In subsection “TT-seq monitors immediate response to CDK9 inhibition”, they can't claim that pol II that is still going through the EEC after CDK9 inhibition is independent of CDK9 function. Is it not more likely that not every CDK9 has been fully inhibited by 10 min treatment of NA? The only (indirect) experimental evidence they have showing that pol II pausing is regulating pol II initiation at the promoter is the decrease in TT-seq signal between the TSS and the pause site after CDK9 inhibition. The problem here is that it is not entirely clear whether CDK9 activity is doing something upstream of the pausing site and is involved in elongation between the TSS and the pause site.</p></body></sub-article><sub-article article-type="reply" id="SA2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.29736.044</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Comments are provided for revision:</p><p>1) Prior cell-free transcription experiments have shown large effects on mRNA synthesis due to pause-release under conditions that do not support enhancer-linked transcription initiation or chromatin templates to facilitate transcription reinitiation. The differences in pause frequency and strength between different promoters can also be recapitulated in vitro in the absence of long-range connections between enhancers or chromatin- the resulting changes in mRNA levels in these studies are quite large and P-TEFb/NELF-DSIF-dependent. Should the changes in initiation secondary to pausing observed here be more accurately described as indirect? Or would 4sU-seq and NET-seq reveal a stronger effect on initiation in these systems?</p></disp-quote><p>We appreciate these insightful comments. We carefully considered whether we should describe the changes as indirect. We wish to maintain the current wording. One may argue that steric exclusion of PIC assembly is a direct, not an indirect, effect. Also, it may be that the word indirect leads readers to think that one must assume additional mechanisms, such as posttranslational modification etc. to explain the effect of pausing on initiation, but this is not the case.</p><disp-quote content-type="editor-comment"><p>2) The authors should comment on the fact that the estimates for pause duration and initiation frequency in subsection “Multi-omics analysis provides pause duration d and initiation frequency I” disregard any differences there might be in transcriptional processivity between different genes and regions.</p></disp-quote><p>This is an important point. It is correct that transcriptional processivity is not modeled in a gene-wise manner as far as if it happens at the pause site. However, early termination that might occur upstream of the pause site is irrelevant to our model and its conclusions. Additionally, <xref ref-type="fig" rid="fig4s1">Figure 4 —figure supplement 1</xref> shows that early termination events at the pause site occur rarely if at all. The minor role that transcriptional processivity might play is also negligible for the conclusions we draw on metagene analysis, involving 500 up to more than 2000 genes. We nevertheless made sure that we point out in the main text that the possibility exists that a fraction of paused polymerases is lost, i.e. processivity at this step is not 100%.</p><disp-quote content-type="editor-comment"><p>3) Why are the position-markers truncated in '<xref ref-type="fig" rid="fig1">Figure 1</xref>' and '<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>'? The rulers should cover the whole genomic area shown in the figure above.</p></disp-quote><p>We thank the reviewers for this helpful comment. We changed the figures accordingly.</p><disp-quote content-type="editor-comment"><p>4) Introduction: Consider inserting 'underlying' so the sentence reads: &quot;The mechanisms underlying how Pol II pausing can regulate…..&quot;</p></disp-quote><p>We have added this change to the main text.</p><disp-quote content-type="editor-comment"><p>5) Cite Saponaro et al., 2014, who also published on elongation speeds using the techniques referenced in subsection “Pol II elongation velocity is gene-specific”.</p></disp-quote><p>We thank the reviewers for pointing this out. We have added this citation.</p><disp-quote content-type="editor-comment"><p>6) The authors have not directly analyzed initiation or the formation of pre-initiation complexes as was done by Shao and Zeitlinger, 2017. As such, they should use the term &quot;pause release&quot; rather than 'initiation frequency' given that the data are focused on pol II release from the pausing site. 7)</p></disp-quote><p>Shao and Zeitlinger exclusively used occupancy measurements of transcription factors. Note that an increase in occupancy can stem from a higher initiation frequency, but also from a longer live time of the PIC or from filling of unbound promoters in a cell population. TT-seq however measures RNA production at each genomic location. The TT-seq signal in genes measures the number of RNA-producing polymerases that initiated from the promoter and were successfully released form the pause site, i.e. the ‘productive initiation frequency’. Using the term ‘pause release’ for the initiation frequency would lead to many misunderstandings. The term ‘pause release rate’ would refer to the rate at which a paused polymerase is released, but this is conceptually different from the productive initiation frequency, and it is a critical point of the paper to say this. In order to avoid such confusion, we wish to maintain the term ‘productive initiation frequency’. It is true that this is only identical to the initiation frequency if no paused polymerases undergo early termination, but we show that the fraction of such early terminating polymerases is low. To account for the possibility of a fraction of Pol II terminating early, we added the term ‘productive’ to the term ‘initiation frequency’. We went through the entire text again and made sure it is all consistent, the right terminology is used throughout, and that misunderstandings are avoided.</p><disp-quote content-type="editor-comment"><p>7) In subsection “TT-seq monitors immediate response to CDK9 inhibition”, they can't claim that pol II that is still going through the EEC after CDK9 inhibition is independent of CDK9 function. Is it not more likely that not every CDK9 has been fully inhibited by 10 min treatment of NA? The only (indirect) experimental evidence they have showing that pol II pausing is regulating pol II initiation at the promoter is the decrease in TT-seq signal between the TSS and the pause site after CDK9 inhibition. The problem here is that it is not entirely clear whether CDK9 activity is doing something upstream of the pausing site and is involved in elongation between the TSS and the pause site.</p></disp-quote><p>The reviewer is correct that we cannot be certain of this point. We have therefore included a corresponding statement that we cannot exclude that CDK9 inhibition was incomplete. However, according to the distribution shown in <xref ref-type="fig" rid="fig1">Figure 1E</xref>, and the additional genome browser views pasted below (see <xref ref-type="fig" rid="respfig1">Author response image 1</xref>), where the response is around 90%, the portion of CDK9 that has not been fully inhibited by 10 min treatment with 1-NA-PP1 must be very low. This conclusion is based on the assumption that the inhibitor is evenly distributed across cells and within cells. Note also that inhibitory effects on pausing observed until now might have been also caused by unspecific inhibition of other kinases.</p><fig id="respfig1"><label>Author response image 1.</label><caption><title>Example genome browser views of TT-seq signals in CDK9<sup>as</sup> cells with high responsiveness (~ 90%).</title><p>(<bold>A</bold>) CYB5R4 gene locus (107,781 [bp]) on chromosome 6. The upper panel shows TT-seq signal with CDK9<sup>as</sup> inhibitor (red) and control (black). Grey box depicts transcript body from transcription start site (TSS, black arrow) to polyA site (pA). (<bold>B</bold>) AGPAT6 gene locus (47,814 [bp]) on chromosome 8 depicted as in (<bold>A</bold>). (<bold>C</bold>) PYGB gene locus (49,945 [bp]) on chromosome 20 depicted as in (<bold>A</bold>).</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-29736-resp-fig1-v2"/></fig></body></sub-article></article>